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Chapter 1: STRUCTURE AND AIMS OF THE THESIS 
 
 
  1. AIMS OF THE STUDY 
 
     The research developed within this PhD thesis has been developed according to different specific 
objectives depending on the selected plant. Overall the choice of these two matrices, the fruit of 
pomegranate and the root of capper, is related to the importance of these plant in Syria as better 
underlined in the next paragraphs. 
 
     POMEGRANATE FRUIT.  
 
     Due to the growing awareness of the contribution of diet to the health by consumers, the 
potential health benefits of pomegranate have led to a substantive increase of the popularity as 
well as worldwide marketing of such fruit and its juice. Its biological properties have been 
mainly attributed to polyphenolic compounds, such as anthocyanins and ellagitannins which 
greatly have contributed to the development of pomegranate-derived products present on the 
market. The comprehensive analysis of phenolic fingerprinting of the different parts of this fruit 
is a crucial starting point for assessing their biological and nutritional properties and to enhance 
the use of the whole fruit. 
    The principal objective of this first part of the work was to investigate on the discharge parts, 
mesocarp and exocarp of pomegranate fruits from the two varieties Laffan and Wonderful. To 
this aim all samples derived by water extractions have been treated to precipitate the crude 
polysaccharide. Overall, for the extraction only water and ethanol have been selected. A quick 
and efficient HPLC/DAD method was then applied to quantify and compare the different 
extracts in terms of HTs content. The quantitative data have been targeted to evaluate  the 
ellagitannins, particularly punicalagins and ellagic acid derivatives. The main results regarding 
the tannin content are summarized in the draft of the work reported in Chapter 4 of this thesis.  
     Furthermore, another class of metabolites, really little studied to date,  is a target of this research: 
the polysaccharides of this fruit . The efforts were targeted to : determine the amount of crude 
polysaccharides (CPS) in mesocarp and exocarp of  Laffan and Wonderful cvs,   optimize the 
process in terms of shorter time and higher yield of CPS, determine  the sugar composition.  
Finally  an  in vitro evaluation of the prebiotic properties of these CPS   on bifidobacteria and 
lactobacillus genera was carried out. The principal findings on CPS of pomegranate are 
illustrated and discussed in the Chapter 5 of this thesis. 
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     It can be affirmed that our results allowing to improve the knowledge on the composition of 
these fruit-wastes contribute to valorise these by-products. Furthermore, the ability of these CPS 
to positively interact with well known probiotic agents, can open new perspectives for their 
potential  use  as food components able to positively interact with the human microbiota. 
 
     CAPPARIS SPINOSA ROOT.  
 
     Caper (Capparis spinosa L.) is one of the underutilized plant species in Syria. It is a wild spiny 
shrub, well adapted to harsh environments, dry heat and intense sunlight.  In Syria the plants are 
collected to be traded by  Syrian rural communities, in particular can be a resource for poor 
nomadic families living in the desert, and contribute to generate an important additional income. 
Products derived by caper are sold in herbal shops in Syrian towns and their use is well known 
by herbalists. Thanks to its economic importance and medical value but also to low cultivation 
requirements and good tolerance to adverse environmental conditions, the caper can contribute to 
livelihood of many small farmers.  
     Aim of this work was to improve the knowledge on the alkaloid content of the root of a Syrian 
sample of C. spinosa.  Decoct and  hydro-alcoholic and dichloromethane extracts have been 
prepared and analyzed by HPLC-DAD-MS. The different extracts obtained from the whole 
powdered root and from root cortex and the internal part separately have been evaluated in terms 
of alkaloids amounts. Moreover, preliminary findings from in vivo test on rats have pointed out 
the capacity to reduce the osteoarticolar pain in rats of different root extracts of caper partially 
confirming the traditional use of this plant. Overall this thesis highlights the importance to 
improve the knowledge of the chemical compositions of the plant to support the medical and 
traditional uses of Capparis spinosa L roots. 
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Chapter 2:  PUNICA GRANATUM L. 
 
 
2.1.THE VALUE OF POMEGRANATE  
The value of pomegranate is its large content in polyphenol compounds, which are present in 
the edible part as well as in the rest of the fruit, Pomegranate has a long history of nutritional 
(when consumed as raw fruit or juice) value. Apart from being eaten fresh, pomegranates 
are used to make juice, which is consumed around the world. About 100 g arils provides 72 
kcal of energy,1.0 g protein, 16.6 g carbohydrate, 1 mg sodium, 379 mg potassium,13 mg 
calcium, 12 mg magnesium, 0.7 mg iron, 0.17 mg copper,0.3 mg niacin and 7 mg vitamin C 
(Grove and Grove, 2008).And reported as an interesting source of essential vitamins as 
folate and vitamin K (USDA, 2010).  In addition to the preferred consumption of 
pomegranate juice (PJ), extracts are used to prepare numerous products to exploit the 
specific nutritional and health-related properties of pomegranate phytochemicals. 
Pomegranate peel extracts have been found to be suitable for applications in the food 
industry as they are an important source of phenolics, flavonoids and tannins occurring as 
natural ingredients and co-products of PJ-related prepara-tions (Viuda-Martos et al., 2010, 
2013). It is well known that pomegranate is a good source of anti-oxidants. However, as 
Salgadoet al. (2012) have shown, the anti-oxidant content of the other juices such as tomato 
and orange juice with strawberries can also be also be improved by the addition of as much 
as 0.5% dried pomegranate peel extracts to the juice. Pomegranate juice and seeds are used 
to make toppings, sauces and dips for many types of food. There are about 153 
phytochemicals, including their derivatives, in pomegranate. Polyphenols are the major class 
of phytochemicals extracted from almost all parts of pomegranate tree, but are most 
abundant in fruits, primarily the peels. Phyto-nutrients derived from pomegranate fruits offer 
the best protection against many diseases (Jyotsana  and Maity,2010). Pomegranate peel 
extract might be useful as multi-functional preservative in foods (Ibrahim, 2010).  The seeds 
of pomegranate fruits from Nigeria and Saudi Arabia showed significant differences in the 
percentage of ash, moisture, crude lipid, crude protein, crude fibre, available carbohydrate 
and energy value. Elemental analyses show that magnesium is the most abundant elements 
in the seeds of both countries (5650 mg/100 g and 1140.1 mg/100 g in Nigeria and Saudi 
Arabia, respectively) (Dangoggo et al., 2012). Human consumption of anthocyanins is 
increasing because of the growing awareness and interest in their potential health benefits. 
Pomegranate is one of the major sources of anthocyanins (Fischer et al., 2011a), 
4 
 
Pomegranate fruit parts also find use as nutrient feeds for ruminants. Taher-Maddah et al. 
(2012) recently developed the use of pomegranate seed and peel, which are by-products of 
the PJ industry in Iran, as a possible nutritive supplement there by reducing the dependence 
on cereal supplements of the ruminant diet. They showed that ensiled and dried seeds are a 
good nutritive source. However, it is a point worth mentioning the increasing role of 
seed oil in establishing the pharmacological mechanisms of pomegranate. 
 Recent scientific findings corroborate traditional usage of the pomegranate as a medical 
remedy and indicate that pomegranate tissues of the fruit, flowers, bark, and leaves contain 
bioactive phytochemicals that are antimicrobial (Hazeleger et al 2012). reduce blood 
pressure, and act against serious diseases such as diabetes and cancer. These findings have 
led to a higher awareness of the public to the benefits of the pomegranate fruit, particularly 
in the western world,and consequently to a prominent increase in the consumption of its fruit 
and juice. The development of industrial methods to separate the arils from the fruit and 
improvement of growing techniques resulted in an impressive enlargement of the extent of 
pomegranate orchards (Holland et al., 2009).  
 
2.2. TAXONOMY AND MORPHOLOGY  
 
Botanical Classification  
The pomegranate family has a single genus Punica with two species viz., P. granatum and 
P. protopunica. The latter is considered to be the ancestor of the genus Punica which might 
have contributed to the evolutionary process of the cultivated form of pomegranate. P. 
protopunica is endemic to Socotra Islands (Yemen) and is the only relative of the cultivated 
pomegranate (Zukhovskij,1950; Moriguchi et al., 1987; Guarino et al., 1990 ;  Levin and 
Sokolova , 1979 ; Mars 1999; Levin 2006).and P. protopunica differs in having pink unlike 
the red flowers of P.granatum and smaller, less sweet fruit. Over 1000 cultivars of P. 
granatum exist  (Levin G.M.,1994).In India, the fruits of the wild pomegranate have thicker 
rinds and extremely high acidity compared with cultivated types (Bist et al., 1994).They are 
also reported to have much smaller arils (Kher,1999). In Central Asia, the primary 
difference noted is the higher acidity in wild material (Kerimov, 1934). 
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Table 1 .Systematic of pomegranate (Punica granatum L.)    
 
Vegetative Growth 
Pomegranate is a shrub that naturally tends to develop multiple trunks and has a bushy 
appearance. When domesticated, it is grown as a small tree that grows up to 5m. Under 
natural conditions, it can sometimes grow up to more than 7m; at the other extreme, in 
severe natural environment, one can find creeping bush varieties (Levin 2006). In addition, 
there are dwarf cultivars that do not exceed 1.5m(Levin 1985, 2006; Liu 2003). Most of the 
pomegranate varieties are deciduous trees. However, there are several evergreen 
pomegranates in India. Singh et al. (2006) 
 
The Flower 
Flowering occurs about 1 month after bud break on newly developed branches of the same 
year, mostly on spurs or short branches. Flowers can appear solitary, pairs, or clusters. In 
most cases, the solitary flowers will appear on spurs along the branches while the clusters 
are terminal. In the northern hemisphere, flowering occurs in April-May. However, 
flowering may continue until end of summer, particularly in young trees. Such flowers are 
fertile, but the fruit will not properly mature because the trees enter the cooler season and the 
dormancy period in Mediterranean climatic conditions. Flowering and the consequent fruit 
set last about 1 month. During this period, there are three waves of flowering (Ben-Arie et 
al. 1984; Shulman et al. 1984; El Sese 1988; Assaf et al. 1991b; Hussein et al. 1994; Mars 
2000). In evergreen cultivars in southern India, flowering season was observed in three 
Botanical 
Name   
Punica 
granatum 
Division Angiospermae  
Class Magnoliopsida  
Subclass Rosidae 
Order Myrtales 
Family Punicaceae 
Genus Punica 
Species P. granatum 
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periods: June, October, and March (Nalwadi et al. 1973) or throughout the year (Hayes 
1957). 
 
 
The Fruit  
Pomegranate fruits are globose or somewhat flattened, 5–12 cmin diameter,The fruit is 
originated from an infer ovary and contains the arils or seeds, which are the edible part, 
contributing to 55-60 % of the whole fruit ,The aril juice sac is composed of many 
epidermal cells and the colour of the arils range from deep red to virtually colourless 
according to different cultivars  Figure 1 , whereas the enclosed seed varies in content of 
sclerenchyma tissue, which affects seed softness  (Levin, 2006). 
 
 
              Figure 1 - Arils from different pomegranate cultivars 
 
while the skin supposes the 40-45%(Levin, 2006).  There are varieties rich in mesocarp and 
the other poor Figur 2. 
 
   Figure 2 . Different varieties of pomegranate 
The husk is comprised of two parts: the pericarp, which provides a cuticle layer and fibrous 
mat; and the mesocarp (known also as the albedo), which is the spongy tissue and inner fruit 
wall where the arils attach.The multi-ovule chambers (locules) are separated by 
membranous walls (septum) and fleshy mesocarp. The chambers are organized in a non 
symmetrical way. Usually the lower part of the fruit contains 2 to 3 chambers while its upper 
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part has 6 to 9 chambers (Fahan, 1976) divided in several chambers by a horizontal 
diaphragm and vertical septal membranes made of papery tissue, each chamber being filled 
by many seeds crowded on thick, spongy placentae; arils do not attach to septal membranes 
(Lawrence, 1951; Purseglove, 1968; Anonymous, 1969; Dahlgren and Thorne, 1984).  There 
is interest in identifying or developing cultivars that have more locules to fill the fruit 
interior, fewer septal membranes for easier eating, and a thinner mesocarp. (Levin, 
2006).and Skin color ranges from light yellow to deep red as well as the color of the arils, 
depending on the cultivar,although, in general, (Kader, 2006).There are some exceptional 
cultivars, such as the black pomegranate which acquires its black skin very early and 
remains black until ripening time (Figure. 3 ). The skin (leathery exocarp) thickness varies 
among pomegranate cultivars. and also no correlation exists between skin and arils color. 
Chemical composition of pomegranate arils changes as fruit ripens on tree, so it is important 
to know the most appropriated harvest date to have fully ripe fruits with high quality 
attributes, which last from 4.5 to 6 months after full bloom, depending on cultivar and 
agronomic and environmental conditions (Kader, 2006 ; Gil et al. 1995a). 
 
                     Figure.3 - black pomegranate 
 In addition, the genus Punica L. is characterized by several easily distinguishable 
morphological features, such as the fruit with leathery pericarp and the pulpy seeds with 
edible sarcotesta (Dahlgren and Thorne, 1984).The ovules of Punica are thick with a 
multilayered outer integumentand unicellular archesporium (Huang and Shi, 2002). The 
union of the ovary with the receptacle of the thalamus that forms a peculiar type of fruit, 
especially termed as “balusta” is also a very distinctive character of Punica (Nath and 
Randhawa, 1959).The fruit has a prominent calyx, which is maintained to maturity and is a 
distinctive feature of the pomegranate fruit.   
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Levin (2006) reports that occasionally metaxenia is observed such that there are several 
seeds of different color within an individual pomegranate. The arils vary in size and the 
seeds vary in ardness among different varieties. Varieties known as seedless actually contain 
seeds that are soft.There is no correlation between the outer skin color of the rind and the 
color of the arils. These colors could be very different or similar,depending on the variety. 
The external outer skin color does not indicate the extent of ripening degree of the fruit or its 
readiness for consumption because it can attain its final color long before the arils are fully 
ripened. The fruit ripens 5 to 8 months after fruit set,depending on the variety. The most 
pronounced difference in ripening time among cultivars is not derived from the differences 
in flowering dates but rather from the time required to ripening from anthesis.  
The pomegranate tree requires a long, hot and dry season in order to produce good yield of 
high-quality fruit. Pomegranates are native to central Asia, but since the pomegranate tree is 
highly adaptive to a wide range of climates and soil conditions,it is grown in many different 
geographical regions including the Mediterranean basin, Asia, and California( Holland et al., 
2009) 
 
2.3. HORTICULTURAL ASPECTS 
 
Cultivars  
Owing to its wide distribution in many different world regions, pomegranate exhibits a 
broad array of diverse phenotypes and genotypes. Actually, more than 3000 pomegranate 
cultivars have been described. There are pink, red, green, and even almost black 
pomegranate varieties. In addition, some cultivars are well- adapted to the exigencies of the 
current global market, demanding high productivity.  
Interesting pomegranate cultivars were reported from several locations all over the world, 
including Europe (Spain, France, Italy, Greece, and Cyprus), Asia (Turkey, Turkmenistan, 
Kirgizstan, Azerbaijan, Iran,India, China, Russia, Israel), and North Africa 
(Morocco,Tunisia,Egypt). The botanical differences between wild pomegranates and 
cultivated pomegranates are not obvious except for P. protopunica. Pomegranate cultivars 
were spread throughout different regions and continents, and it is probable that some of the 
pomegranate cultivars acquired different names in different countries and are in fact the 
same basic genotypes. (Levin ,1996). 
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Due to market request, it has become increasingly important to characterize the different 
cultivars and genotypes to identify those of high quality product that are economical to 
produce (Martínez et al., 2006).cultivars and types exist across many countries. and  a 
Several cultivars are grown commercially in the world. The names of most of these cultivars 
reflect the color or the shape of the fruit and one cultivar might have different names in 
different countries. The most important cultivars are: 
• 'Ahmar', 'Aswad', and 'Halwa' in Iraq; 
• 'Nab el-Jamal', 'Laffan', 'Sultani', and 'Wardi' in Syria; 
• 'Red Laffani', 'Malissi', and 'Ras el-Baghel' in Palestine; 
• 'Mangulati' in Saudi Arabia; 
• 'Wonderful' in California; 
• 'Mollar' and 'Tendral' in Spain; 
• 'Schahvar' and 'Robab' in Iran; 
• 'Hicaz' in Turkey; 
• 'Zehri' and 'Gabsi' in Tunisia; 
• 'Alandi' and 'Ganesh' in India. (Tubeileh, et al., 2004). 
 
We observe that there are a lot of pomegranate varieties. Among these varieties, in respect 
of fruit taste, there are  sweet, sour and sour-sweet. The last kind is called Loufani in Arabic, 
and some of them are extremely large and weigh an English pound. ( Goor,1967 ).and  very 
littel information is available about these cultivars. ‘Red luofani ’‘Malisi ’and ‘Rasel baghl 
’in syria (Yilmaz, 2007. Morton, 1987).and lefan are some of the most important varieties 
cultivated in Turkey in Hatay with yellow skin, large arils, a sweet-sour flavor, and very 
hard seeds (Ozguven and Yilmaz 2000; Ozguven et al. 2006).  Lefan (or Lifani) the origin of 
this variety is Hatay the fruit color  rind is yellow-red the arlis are pink .the seed hardness 
intermediate( Ozguven, A.I., and C. Yilmaz. 2000 ).also, the Red Loufani,is a synonym of 
'Wonderful'.(Goor and Liberman 1956). The two are very like one another in appearance 
and fruit. Both are late ripening, with a rather sour,   and of excellent quality. And the Red 
Loufani’ and ‘Ras el Baghl’ are local strain from Israel and Palestine (Morton, 1987).and of 
The  principal varieties in the Jewish sector  ( Goor,1967 ). 
Most of the cultivars known today are selections from an unknown origin,mostly chance 
seedlings or mutations collected from places where there are no records documenting their 
origin. However, some cultivars are the result of deliberate crosses. Such cultivars were 
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reported particularly from India (Keskar et al. 1993; Samadia and Pareek 2006), China 
(Zhao et al. 2006; Yang et al. 2007). 
Pomegranates in the New World probably were   imported by  travelers from Europe. There 
is a relatively limited number of pomegranate cultivars in the United States ‘Wonderful’,the 
most important cultivar, originated in Florida and was discovered in Porterville, California, 
about 1896 (LaRue,1980).This cultivar is the most widely planted commercial pomegranate 
cultivar in California.The fruit is a large with red arils, sweet-sour taste, and semihard 
seeds,and it ships well. The external appearance of the fruit is very appealing with red glossy 
color. The several Israeli landraces of ‘Wonderful’ are either ‘Wonderful’ seedlings (most 
likely) or sports. It is unclear whether the American ‘Wonderful’ is genetically 
distinguishable from any of the Israeli ‘Wonderful’ landraces. The American ‘Wonderful’ 
fruit is much harder and less prone to mechanical aril extraction than the Israeli landraces, 
but these differences could reflect variations in growth condi-tions. ‘Wonderful’ is also 
grown in western Europe and Chile (Stover and Mercure 2007). 
In Sicily, Italy. Six Sicilian pomegranate selections were reported by Barone et al. (2001): 
‘Dente di Cavallo’, ‘Neirana’, ‘Profeta’, ‘Racalmuto’,‘Ragana’, and ‘Selinunte’. The local 
accessions were considered less attractive than the Spanish cultivars.Cultivars mentioned as 
important in the literature, but with no descriptions, include ‘Ahmar’, ‘Aswad’, and ‘Halwa’ 
from Iraq; ‘Mangulati’ from Saudi Arabia; and ‘Red Loufani’ and ‘Ras el Baghl’ from Israel 
and Palestine (Morton, 1987).  
 
Origin and cultivating regions  
 Culture of pomegranate began in prehistoric times. It is estimated that pomegranate 
domestication began somewhere in the Neolithic era (Levin 2006; Still 2006). Pomegranate 
s are thought to have been domesticated initially in the Transcaucasian-Caspian region and 
northern Turkey (Zohary and Spiegel-Roy 1975; Harlan 1992).The  wild  or  semi-wild  
pomegranate  still exists   in   the   north   of   Syria,   in   Gilead, “Flora   of   Syria,   
Palestine    and   Sinai   by G.E.   Post” (Goor , 1967) . Evidence for using pomegranates in 
the Middle East is dated at over 5,000 years ago. Pomegranate artifacts and relics dating to 
3000 BCE and on were found in Egypt, Israel Armenia, and Mesopotamia (Goor and 
Liberman 1956; Still 2006; Stepanyan 2007) as  seen  on  the walls  of  Karnak  in  the  
famous  plates  of  the  'Syrian  Garden'  of  that  Pharaoh,  where  pomegranates  figure  
among  the  plants   imported  from  Canaan.(1408-1370 BC.)also' 4 Bells were in 
themselves a symbol of the unfertilized pomegranate flower (male).  4.   Stand   decorated   
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with   pomegranates    (found   at  Ras-Shamra-Ugarib  Syria , late   Bronze  Age)   Figure 4 
(Goor , 1967).   
 
 
figure. 4. Stand decorated with pomegranates (found at Ras-Shamra-Ugarib .Syria .late 
Bronze Age) . 
 
Carbonized fragments of pomegranate rinds dating from early Bronze Age were found in 
Jericho and Arad, Israel  and even mentioned in the Bible and the Koran. (Still, 2006), in 
Nimrod, Lebanon, in Egypt (Still, 2006), and in Armenia (Stepanyan 2007). Pomegranates 
were introduced throughout the Mediterranean region to the rest of Asia to North Africa and 
to Europe. They traveled to the Indian peninsula from Iran about the first century CE and 
were reported growing in Indonesia in 1416. The Greeks and the successor empires 
distributed the pomegranate all over Europe. Spanish sailors brought pomegranates to the 
New World, and Spanish Jesuit missionaries introduced pomegranates into Mexico and 
California in the 1700s (Goor and Liberman 1956; Morton 1987). 
  
Pomegranate is cultivated today throughout the world in subtropical and tropical areas in 
many different microclimatic zones. Commercial orchards of pomegranate trees are now 
grown in the Mediterranean basin (North Africa, Egypt, Israel, Syria, Lebanon, Turkey, 
Greece, Cyprus, Italy, France, Spain, Portugal) and in Asia (Iran, Iraq, India, China, 
Afghanistan, Bangladesh, Myanmar, Vietnam, Thailand; and in the former Soviet  republics: 
Kazakhstan, Turkmenistan, Tajikistan, Kirgizstan, Armenia, and Georgia). In the New 
World, pomegranates are grown in the United States and Chile. New orchards are now 
established in South Africa, Australia, Argentine, and Brazil ( Holland et al., 2009). 
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2.4. Pomegranate production  
Current global production estimates for pomegranate are unavailable due to the rapid 
increase in the production and expansion, although it is estimated that around 1.5 million 
tonnes of pomegranate fruits are produced in the world annually (Holland and Bar-Ya’akov, 
2008). However, it is widely grown in many countries where it is well adapted. In India 
more than 100,000 ha of pomegranate are produced. It is considered one of the most 
important fruits of the tropical and subtropical areas because of low maintenance cost, good 
yields, good keeping quality, and ability to thrive with limited moisture (Indian Council of 
Agricultural Research, 2005). In Iran, 65,000 ha of omegranate produces 600,000 tons of 
fruit annually, with about 30% of yield exported (Mehrnews, 2006). Turkish production in 
1997 was 56,000 tons/year (Gozlekci and Kaynak, 2000). Spain, with ≈3000 ha, is the 
largest western European producer of pomegranate, and production has been increasing as a 
result of high market prices (Costa and Melgarejo, 2000) Syria  is the second largest 
producing country of pomegranates after Tunis in the Arab world (Anonymous,2000). In the 
United States, there are 5600 ha of commercial pomegranate, mostly in the San Joaquin 
Valley. The ‘Wonderful’ cultivar dominates almost completely, but there is interest in 
earlier and later cultivars to extend the market season (Kotkin, 2006).    
 
2.5. BIOACTIVE COMPOUNDS IN POMEGRANATE FRUIT 
While detailed knowledge of relationships of the chemical content of pomegranates and 
their desirable pharmacologic endpoints has yet to be obtained, significant progress has been 
made over the past 8 years toward a much more comprehensive understanding of some of 
the important pharmacologic components of pomegranate. These are summarized, with their 
structures, in Table 2. In addition to the more common anthocyanins shown in the table, 
pentose glycosides of malvidine and pentunidin have been described in the pericarp and 
juice (Sharma and Seshadri, 1955).  
 
 
 
13 
 
Chemical 
class 
Compound 
name 
Compound structure Plant 
part: J: 
juice, 
P:peel 
S:seed  
References 
Hydroxy 
benzoic acids 
Gallic acid 
 
J, P Amakura et 
al. (2000b),   
Hydroxy 
benzoic acids 
Ellagic acid 
 
J, P, S Amakura et 
al. (2000b),  
Wang et al. 
(2004) 
Hydroxy 
cinnamic 
acids 
(phenylpropa
noids) 
Caffeic acid 
 
J, P Artik 
(1998), Ama
kura et al. 
(2000a) 
Hydroxy 
cinnamic 
acids 
(phenylpropa
noids) 
Chlorogenic acid 
 
J, P Artik 
(1998), Ama
kura et al. 
(2000a) 
Hydroxy 
cinnamic 
acids 
(phenylpropa
noids) 
p-Coumaric acid 
 
J, P Artik 
(1998), Ama
kura et al. 
(2000a) 
Flavan-3-ols Catechin 
 
J, P de Pascual-
Teresa et al. 
(2000) 
Flavan-3-ols Epicatechin 
 
J, P de Pascual-
Teresa et al. 
(2000) 
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Flavan-3-ols Epigallocatechin 
3-gallate 
(ECGC)) 
 
J, P de Pascual-
Teresa et al. 
(2000) 
Flavonols Quercetin 
 
J, P Artik (1998) 
Flavonols Kaempferol 
 
P van Elswijk et 
al. (2004) 
Flavonol 
glycosides 
Rutin 
 
P, J Artik (1998) 
Anthocyanidins Delphinidin 
 
P Noda et al. 
(2002) 
Anthocyanidins Cyanidin 
 
P Noda et al. 
(2002) 
Anthocyanidins Pelargonidin 
 
 
 
 
p Noda et al. 
(2002) 
Ellagitannins Punicalin 
 
  P, L, 
B, R 
Tanaka et al. 
(1986 ),Gil 
et al. (2000) 
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Ellagitannins Punicalagin 
 
P, L, 
B, R 
Tanaka et al. 
(1986 ),Gil 
et al. (2000) 
Ellagitannins Corilagin 
 
P, L Satomi et al. 
(1993), 
Nawwar et 
al. (1994 ) 
Ellagitannins Pedunculagin 
 
P Satomi et al. 
(1993) 
Ellagitannins Granatin A 
 
P Tanaka et al. 
(1990) 
Ellagitannins Granatin B 
 
P Tanaka et al. 
(1990) 
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Table .2  Structures of polyphenolic compounds found in pomegranate peel and other parts 
(Punica granatum)  
 
Polyphenol compounds have played a role in the successful evolutionary adaptation of 
plants. They are essential to the plant’s  physiology, being involved in diverse functions 
such as structure, pigmentation, ollination, allelopathy, pathogen and predator resistance, 
growth and development (Croteau et al., 2000; Dewick, 2002). These phenolics are 
primarily derived from the phenylpropanoid and phenylpropanoid-acetate pathways. 
Phenolics range from simple, low molecular weight, single aromatic-ringed compounds to 
large and complex tannins and derived polyphenols. They can be classified into two 
main groups: flavonoids, a structurally diverse group of C15 compounds arranged in a C6- 
C3-C6 configuration and non-flavonoids which include condensed and hydrolysable 
tannins, stilbenes, phenolic acids and hydroxycinnamates(Del Rio et al., 2012). Among 
different kind of (poly)phenolic compounds, pomegranate contains mainly anthocyanins, 
ellagic acid and ellagitannins, gallic acid and gallotannins, flavan-3-ols, and 
proanthocyanidins.   
Anthocyanins  
Anthocyanins are a group of water-soluble natural pigments responsible for the attractive 
red-blue colour of flowers and many fruits, including pomegranate. They may play a role in 
the defence mechanisms of plants (De Pascual-Teresa & Sanchez-Ballesta, 2008). Likewise, 
anthocyanins therapeutic properties are wide-ranging and have been attributed to potential 
human health benefits of berries (de Pascual-Teresa et al., 2010; Seeram, 2008; Tsuda, 
2012). 
Pomegranate presents an anthocyanin profile characterised by six anthocyanins: cyanidin 
3,5-di- and 3-O-glucoside, delphinidin 3,5-di- and 3-O- glucoside, pelargonidin 3,5-di- and 
3-O-glucoside (Gil et al., 1995b). Three new cyanidin derivatives have been recently 
described in pomegranate juice: pentoside, pentoside-hexoside, and rutinoside (Fischer et 
al., 2011a). It is important to note that the amount of these coloured flavonoids is largely 
affected by the cultivar group;  for  instance,  “Wonderful”  variety  is  related  to  cyanidin  
Pelletierine 
alkaloids  
Peelletierine 
 
P Neuhofer et 
al. (1993), 
Vidal et al. 
(2003) 
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3,5-diglucoside instead of cyanidin 3-glucoside, the main anthocyanin for Spanish “Mollar 
de Elche” cultivars (Gil et al., 2000; Pérez-Vicente et al., 2004). 
 
Ellagitannins  
Hydrolysable tannins are, together with condensed tannins, the main group of plant tannins. 
Hydrolysable tannins are polyesters of a sugar moiety and phenolic acids. These compounds 
are easily hydrolysed by diluted acids, bases, hot water, and enzymatic activity and because 
of this fact they are termed “hydrolysable tannins” (Khanbabaee & Van Ree, 2001). They 
are divided into two subclasses according to their structural characteristics: gallotannins and 
ellagitannins. If the phenolic acid is gallic acid, the compounds are called gallotannins. On 
the other hand, ellagitannins are characterised by the presence of, at least, one 
hexahydroxydiphenoyl (HHDP) group, which spontaneously rearranges into ellagic acid 
when hydrolysed (Bakkalbasi et al., 2009). 
With more than 500 structures hitherto identified, ellagitannins form the largest group of 
tannins. They are typical constituents of many plant families whilst the distribution of 
gallotannins in nature is rather limited (Niemetz & Gross, 2005). Nonetheless, despite 
hydrolysable tannins are widely distributed, their occurrence in foodstuffs is limited to a few 
fruits and nuts including raspberries (Rubus idaeus), strawberries (Fragaria ananassa), 
blackberries (Rubus spp.), and persimmon (Diospyros kaki), as well as walnuts (Juglans 
regia), hazelnuts (Corylus avellana), and oak-aged wines as they are leached from the oak 
barrels during wine aging (Landete, 2011). Pomegranate has also been pointed out as a rich 
source of ellagitannins (Gil et al., 2000). 
Ellagitannins are characterised by one or more HHDP units esterified to a sugar core, 
usually glucose. HHDP groups are constituted by oxidative C-C bond formation between 
neighbouring galloyl residues. This complex class of polyphenolics can be categorized 
according to their structural characteristics into four major groups: monomeric ellagitannins, 
C-glycosidic ellagitannins with an open-chain  glycoside  core,  oligomers,  and  complex  
tannins  with  flavan-3-ols(Yoshida et al., 2010). In addition, as noted earlier, HHDP moiety 
spontaneously undergoes lactonization to yield ellagic acid upon hydrolysis (Figure 13). 
Ellagic acid can be found in its free form or as ellagic acid derivatives through methylation, 
methoxylation, and glycosilation (Maas et al., 1991).  
 
A broad array of ellagitannin structures have been found in pomegranate juice, doing of 
these hydrolysable tannins the main class of identified (poly)phenolics in pomegranate juice 
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(Borges et al., 2010; Fischer et al., 2011b). Ellagitannins are extensively found in 
pomegranate husk, mainly punicalagins (Gil et al., 2000). Punicalagin isomers (Figure 14) 
are ellagitannins in which gallagic and ellagic acids are linked to a glucose molecule [2,3-
(S)-hexahydroxydiphenoyl-4,6- (S,S)-gallagyl-D-glucose] and are usually extracted into 
juice during processing. Thus, the extraction process determines the amounts achievable in 
juice, displaying important differences between whole-fruit juices and arils-made ones (Gil 
et al., 2000). These compounds, when exposed to pH variations, are hydrolysed and the 
HHDP spontaneously rearranges into the water-insoluble ellagic acid. Likewise, this 
hydrolysis also renders punicalin (Figure 5), a gallagyl residue bounded to glucose (Clifford 
& Scalbert, 2000). Punicalin is other bioactive compound of pomegranate that has generated 
interest with regard to human health (Kasimsetty et al., 2010). 
 
 
Figure 5 - Proposed pathways for the conversion of ellagitannins to ellagic acid and 
urolithins in anaerobic faecal suspensions (González-Barrio et al., 2011) 
 
Other compounds 
Other phenolic compounds distinct from anthocyanins and ellagitannins have been described 
in pomegranate fruit. Catequin and gallocatechin have been identified as the major flavan-3-
ols (De Pascual-Teresa et al., 2000). Likewise, prodelphinidins, a kind of condensed tannins 
derived from the polymerisation of gallocatechin, have also been found in pomegranate peel 
(Plumb et al., 2002). In addition, recently 35 flavanol-anthocyanin adducts have been 
detected in pressure extracted pomegranate juice (Sentandreu et al., 2010). Other 
phytochemicals such as phenolic acids and lignans have also been described in this juice 
(Bonzanini et al., 2009; Fischer et al., 2011a Fischer et al., 2012). Regarding potent 
antioxidant quercetin, it has also been recorded along with other flavonols, although 
quantities were not significant (Artik, 1998). 
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Integral use and pomegranate-derived products 
Pomegranate fruits can be transformed into different food products: juices and beverages, 
wine, jams and jellies, dried arils, and fresh arils in modified atmosphere. Therefore, 
depending on the target product, flow diagram could be slightly turned over. Some of these 
products allow to extend the self-life of pomegranate fruits. On the other hand, the use of 
wastes such as peels and kernels to obtain extracts rich in  polyphenol  compounds and seed 
oil, respectively, entails the integral use of pomegranate fruits Figure 5.  
 
 
 
                             
Figure 5 - Proposed flow diagram for integral use of pomegranate fruits by producing 
pomegranate juice and revalorising by-products  
 
Other pomegranate-derived products 
Molasses pomegranate The pomegranate molasses is commonly used in salad and many 
other dishes in Turkey and Syria  (Marti et al.,2001; Poyrazoğlu et al., 2002; Altan and 
Maskan, 2006) Traditional methods are still being used to produce pomegranate molasses. It 
is concentrated simply by boiling, without the addition of further sugar or other additives 
(Tekeli, 1965; Gökçen et al., 1982; Uylaşer, and Başoğlu. 2000), to ensure long-term  
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storage . and the  total polyphenol contents were found to be in between 551.61 and 9695.17 
mg/kg.Karaali et al. (2006) identified this value to be 3100 mg/kg in pomegranate pulp and 
1860 mg/L in juice.  Total phenolic content of pomegranate molasses was very high in the 
research of Yılmaz et al. (2007) and reported as 52.6 mg gallic acid equivalent (GAE)/g. 
Extracts pomegranate peel Polyphenol extracts: Pomegranate peel, which is a by-product of 
pomegranate juice  processing, is a rich source of antioxidants compared to edible arils and 
can be used as a nutraceutical upplement due to its elevated content in ellagic acid, 
ellagitannins, gallotannins, and anthocyanins (Espín et al., 2007; Madrigal-Carballo et al., 
2009). There are increasing numbers of pomegranate supplements in retail markets owing to 
the popularity of health benefits associated with pomegranate juice (Zhang et al., 2009). 
Commercially available pomegranate supplements are produced as three main different 
types of formulations: capsules, tablets, and soft gels when used for cosmeceutical industry. 
and   On the other hand, pomegranate peel without extraction processes can also be used as a 
functional ingredient for juices (Navarro et al., 2011). 
 
2.6 POMEGRANATE AND HUMAN HEALTH 
 
Therapeutic applications of pomegranate in medicine folk 
Phytotherapy is considered as a complementary approach for preventing and treating simple 
disease, although well grounded in medical tradition, it often lacks proper scientific 
validation (Cravatto et al., 2010). and in Ayurvedic medicine the pomegranate is considered 
“a pharmacy unto itself,” (Naovi  et al., 1991). Fruits,  peels  and  roots  of pomegranate 
have been commonly used in herbal remedies by local healers  in  many  countries.  
Pomegranate  peels  have  been  used  in traditional medicine for treating diarrhea and 
dysentery (Ahmad and Beg, 2001; Braga et al., 2005; Voravuthikunchai et al., 2005; Reddy 
et al., 2007). In Yemen and other countries of the Arabian Peninsula,dried  peels  have  been  
traditionally  used  for  treating  stomachache and for healing wounds. In this regard, 
astringency is a known  pharmacological  property  of  tannins  (Fleurentin  and  Pelt,1982; 
Cowan, 1999).  the bark and roots believed to have anthelmintic and vermifuge properties 
(Naovi  et al., 1991),today is documented in  Italy and Bulgaria (Leporatti & Ivancheva, 
2003). and the rind a traditional Chinese medicine used as antibacterial,  anti-inflammatory 
and hemostasis agent, also  for the treatment  metrorrhagia, metrostaxis and bellyache. is 
rich of phenolic compounds (Lei et al., 2003  ;  Panchavarnakili et al., 2012). the peels a 
powerful astringent and cure for diarrhea and oral aphthae, and the juice a “refrigerant” (  
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Arseculeratne  et al., 1985) and “blood tonic” (Lad et al., 1986) . Authors from India  , 
Tunisia and Guatemala((Nagaraju  et al., 1990 ; Boukef  et al., 1982; Caceres  et al., 1987) 
reported that the dried pomegranate peels are decocted in water and  employed both 
internally and externally for numerous problems demanding astringents and/or germicides, 
especially for aphthae, diarrhea and ulcers. Mixtures of pomegranate seed, juice and peel 
products paradoxically have been reported to not only prevent abortion (Ramirez  et al., 
1988) but also conception (Gujral  et al., 1960 ;  Zhan  et al., 1995) . In Unani medicine, a 
Middle Eastern traditional medical system that later took root in India (Izhar et al., 1989)  
pomegranate flowers serve as a remedy for diabetes mellitus (Saxena et al., 2004). Finally, 
the flowers of P. granatum are used in folk medicine for the treat-ment of bronchitis, 
diarrhea, dysentery, ulcers, hepatic damage,sore eyes, and diabetes (Kirtikar and Basu, 
2000). 
 
Therapeutic applications of pomegranate today 
The role of pomegranate on folk medicine has been largely established and in recent years a 
notable increase of scientific support has occurred. Evidence suggests that phenolic 
phytochemicals of pomegranate fruit, mainly anthocyanins and ellagitannins, could exert 
multiple therapeutic properties on health management as playing an essential role in 
oxidative stress balance, preventing important cardiovascular diseases, and fighting as 
chemoprotective agent against several kinds of cancer. In addition, pomegranate antioxidant 
bioactives could possess a role as neuroprotectors in some neurological disorders just as 
broad antimicrobial activities among other beneficial implications. 
 
Pomegranate and oxidative stress 
 
Pomegranate polyphenols have been suggested like antioxidant compounds and it has been 
confirmed on biological system. Research in animals and humans has demonstrated how 
pomegranate derivatives increase plasma antioxidant capacity and decrease oxidative stress, 
as lipid peroxidation as formation of protein carbonyl (Chidambara Murthy et al., 2002; 
Faria et al., 2007; Guo et al., 2008 ). The protective effect of pomegranate against hepatic 
oxidative stress after prolonged ingestion of pomegranate derivatives has also been pointed 
out in two different animal models (Chidambara Murthy et al., 2002; Faria et al., 2007). 
A point worth mentioning is how pomegranate antioxidants really act against oxidative 
stress. The protective effects of pomegranate bioactive compounds on oxidative stress have 
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been traditionally attributed to their ability as free radicals quenchers, diminishing the levels 
of ROS and, hence, lipid peroxidation and protein damage (Chidambara Murthy et al., 
2002). Nevertheless, pomegranate health features should not be related to an antioxidant 
activity of polyphenols per se, as free radical scavengers, rather than the role of polyphenol 
metabolites in vivo, as signalling molecules able to exert modulatory actions in cell 
pathways (De Nigris et al., 2007a; Guo et al., 2008; Rosenblat et al., 2010). Actually, 
original pomegranate phytochemicals  are  usually  absorbed  and metabolised in other 
bioavailable compounds that can vary their biological properties, even losing their free-
radical scavenging activity, as it occurs to the main ellagitannins metabolites registered in 
plasma, urolithins (Cerdá et al., 2004). However, this lack of direct antioxidant activity does 
not prevent these metabolites from exerting health benefits. Concerning this, in vivo 
metabolites, and not those phenolics present originally in fruits, seem to be the real 
responsible compounds for the protective effects linked to pomegranate consumption, and 
not necessarily due to a radical scavenging ability. 
 
Pomegranate and cardiovascular diseases  
 
The effects of pomegranate-derived products on prevention and attenuation of 
atherosclerosis have been largely tested, showing multiple anti-atherogenic effects (Aviram 
& Rosenblat, 2004; Aviram et al., 2008; de Nigris et al., 2007a). A study carried out with 
hypercholesterolemic mice, fed with high-fat diet, also exhibited the protective effects on 
atherosclerosis of a prolonged (6-months) pomegranate derivatives supplementation (de 
Nigris et al., 2007b). On the other hand, significant reductions  in  atherosclerotic  lesion  
size  were  noted  upon consumption of pomegranate by-products for 3 months by 
apolipoprotein E- deficient mice (which develop atherosclerotic injury similar to that 
displays in humans). The cardioprotective effect of pomegranate by-products on 
atherosclerotic lesion was attributed to macrophage oxidative stress attenuation along with a 
decrease in the extent of oxidised low-density lipoprotein uptake by macrophages since their 
lipids were oxidised in a lesser degree (Rosenblat et al., 2006). Likewise, in another trial 
carried out in hypertensive patients, a decrement in systolic blood pressure was also noted 
together with a reduction in serum angiotensin converting enzyme activity, which indicated 
pomegranate juice effects on attenuating the progression of atherosclerosis (Aviram & 
Dornfeld, 2001). 
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An approach on elucidating the responsible compound(s) for this anti- atherosclerotic 
activity by testing different pomegranate fruit parts has been reported. Aviram et al. (2008) 
pointed out that pomegranate juice and pomegranate arils extract, they both rich in 
anthocyanins, show a major influence in the drop of serum oxidative stress in contrast to 
pomegranate peel extracts, rich in hydrolysable tannins, which display a higher beneficial 
effect on the extent of oxidised low-density lipoprotein uptake by macrophages and on their 
oxidative status. Overall, pomegranate juice showed better anti-atherogenic properties than 
pomegranate peel extracts. Likewise, pomegranate juice was more  potent than pomegranate 
peel purified phenolics like anti-atherogenic product. 
On the other hand, pomegranate phenolics do not seem to modify serum cholesterol (both 
LDL- and HDL-cholesterol) levels, as well as other serum biochemical parameters (glucose, 
triacylglycerol, sodium, and potassium), in in vivo trials (Aviram et al., 2004; Aviram et al., 
2008; de Nigris et al., 2007a;  ), except for studies performed either in hyperlipidemic or 
hypercholesterolemic patients or animals, where LDL-cholesterol values were lowered 
(Bagri et al., 2009 ).  
 
Pomegranate and cancer 
 
Pomegranate, due to its phytochemical composition, has demonstrated to possess potential 
effects on multiple cancer such as colon, prostate, and breast, using cell lines and animal 
models assays. 
Pomegranate juice and its constituents have been broadly studied for their antiproliferative 
and apoptotic activities in human cell cultures of colon cancer since they could exert their 
chemoprotective properties on the colon epithelium through a direct contact. Ellagitannin-
derived compounds (punicalagins and ellagic acid) showed antiproliferative activity against 
all colon tumour cell lines tested (HT-29, HCT116, SW480, SW620), but in a lesser degree 
than pomegranate juice, which displayed the most prominent effect (Seeram et al., 2005). 
The superior bioactivity of pomegranate juice compared to its purified polyphenols was 
attributed to synergies in the way of action of multiple compounds presented in pomegranate 
juice. Likewise, ellagic acid and punicalagin induced apoptosis in human colon 
adenocarcinoma Caco-2 cells but interestingly not in normal colon CCD-112CoN cells  
(Larrosa  et  al.,  2006).  Ellagitannin-Derived metabolites, urolithin-A and –B, were also 
studied in Caco-2 cells. Novel gene expression profiles and deregulation of cellular 
functions related to cell cycle and proliferation  were identified, suggesting that both ellagic 
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acid and urolithins-A and –B may exert a modulating role in the progression of colorectal 
cancer (González-Sarrías et al., 2009).    
The occurrence of urolithins in the human prostate gland upon consumption of pomegranate 
juice have positioned pomegranate as an ideal chemopreventive agent against prostate 
carcinoma in humans (González-Sarrías et al., 2010). Antiproliferative and proapoptotic 
activities of pomegranate derivatives have been evaluated in vitro in various cell lines of 
human prostate cancer. Antiproliferative properties of pomegranate ellagitannin metabolites, 
ellagic acid and urolithins, on androgen-dependent (LNCaP) and –independent prostate 
carcinoma cell lines (LNCaP-AR, DU145, and 22Rv1) in a dose-dependent manner have 
been confirmed (Seeram et al., 2007). It is also a point worth mentioning the fact that a 
combination of both different compounds and discrete fractions of pomegranate fruit have 
reflected possible synergies against cell proliferation (Lansky et al., 2005). In addition, a 
phase II clinical trial in men with recurrent prostate cancer and rising prostate-specific 
antigen (PSA) levels was conducted (Pantuck et al., 2006). Patients were supplemented with 
8 ounces (~240 mL) of pomegranate juice daily until disease progression and results showed 
a significant prolongation of PSA doubling time. Consequently, prospects regarding 
chemopreventive properties of pomegranate juice and its constituents on prostate 
adenocarcinoma were substantially raised. 
 
Pomegranate and neurological disorders  
 
Unlike many other pathologies, protective effects of pomegranate on neurological disorders 
have been scarcely studied. Nonetheless, a few studies have been performed on animal 
models suggesting the promising potential of pomegranate bioactives in the prevention and 
treatment of some neurological disorders. Like that, transgenic mice with an Alzheimer’s 
disease-like  pathology were supplied with pomegranate juice during their old age delaying 
the onset of cognitive impairment and enhancing the learning, as well as reducing 
significantly the accumulation of soluble amyloid-β and amyloid deposition in the 
hippocampus, a process related to disease progression (Hartman et al., 2006). 
 
Pomegranate and antimicrobial effects  
 
Pomegranate has been employed in folk medicine for the treatment of various microbial 
infections and, in fact, the potential antimicrobial properties of pomegranate are recently 
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being studied with promising results. Pomegranate extracts have displayed antagonist effects 
against all type of microorganisms causing  urinary  tract  infections  (El-Sherbini  et  al.,  
2010;  Endo  et  al.,  2010;  ). Consequently, pomegranate-derived products represent an 
attractive prospect for the development of new management therapies for treatment of multi-
drug resistant urinary tract infections. 
On the other hand, pomegranate sun-dried rind is employed in some regions of India as an 
anti-malarial herbal preparation. The role of tannins-rich pomegranate rind methanolic 
extract on the treatment of cerebral malaria, a complication of the infection by Plasmodium 
falciparum, has been studied. Positive results were attributed to the anti-parasitic activity 
and the inhibition of pro- inflammatory mechanisms involved in the onset of malaria 
(Dell'Agli et al., 2010). 
 
Pomegranate and other diseases  
 
The most significant or, at least, more researched pomegranate therapeutic properties have 
been aforementioned, nevertheless, there are some other applications which have offered 
satisfactory results. In this sense, consumption of pomegranate derivatives has been related 
to possess anti-inflammatory activity and has been tested in various animal models. 
Pomegranate polyphenols extract strongly delayed the initiation, reduced the morbidity, and 
lowered the severity of collagen-induced arthritis in mice (Shukla et al., 2008). Likewise, 
another ellagitannins-rich pomegranate extract has shown to decrease oxidative stress in an 
inflammatory bowel model of rat, although it can not avoid colonic damage instead of 
urolithins-A, which reduced significantly colonic lesions. These differences regarding 
ellagitannins and their gut microbiota metabolites actions could be due to the inability for 
urolithins formation of colon-damaged rats (Larrosa et al., 2010). 
 
2.7. TOXICOLOGY STUDIES OF POMEGRANATE  
For thousands of years, Pomegranate has been widely consumed in many different cultures, 
by considering this fruit is generally safe. Studies of pomegranate constituents in animals at  
concentrations and levels commonly used in folk and traditional medicine did not indicate 
any toxic effects. Toxicity of the polyphenol antioxidant punicalagin, abundant in 
pomegranate juice, was evaluated in rats. No toxic effects or significant differences were 
observed in the treatment group compared to controls, which was confirmed via 
histopathological analysis of rat organs (Cerda et al., 2003).  
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Research in 86 overweight human volunteers demonstrated the safety of a tableted PFE in 
amounts up to 1,420 mg/day (870 mg gallic acid equivalents) for 28 days, with no adverse 
events reported or adverse changes in blood or urine laboratory values observed (Heber et 
al., 2007). Another study in 10 patients with carotid artery stenosis demonstrated PJ 
consumption (121 mg/L EA equivalents) for up to three years had no toxic effect on blood 
chemistry analysis for kidney, liver, and heart function. (Aviram et al., 2004).it would seem 
that hydroalcoholic extracts of Punica granatum fruit are innocuous when directly 
administered via the nasal cavity .It was shown that toxic effects of Punica granatum fruit 
extract occurred at higher doses   from those antiviral  or those used in Cuban traditional 
medicine  (Vidal et al ., 2003) . 
The toxic activity of a Punica granatum bark extract was related to its alkaloid content 
according to Tripathi and Singh (2000).The presence of alkaloids (e.g., pelletierine) in the 
peel is equivocal,positive by Dragendorff assay, but negative by Mayer assay (Vidal et al., 
2003). According to Ferrara et al. (1989) the toxic effects of some medicinal preparations of 
Punica granatum may be explained by its pseudo-pelletierine content.   
Some people are allergic to Punica granatum. Several adverse reactions to pomegranate, 
including severe symptoms such as anaphylactic shock or laryngeal edema, have been 
described in recent years(Gaig et al., 1999).   
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Chapter 3: CAPPARIS SPINOSA L. OR CAPPER 
 
 
Capparis spinosa L. (family Capparidaceae) is a plant originating from dry regions in west or 
central Asia and spread particularly across the Mediterranean basin. (Baytop, 1984; Çalis, et 
al., 1999) Figure 1 ,The geographical location of Syria has provided an ideal environment for 
the growth  C. spinosa,which can be found growing wild  everywhere in Syria around dry and 
rocky areas.  but are particularly abundant in the harsh environments of the Euphrates valley , 
Aleppo province,Idlib, Salamie area of the Hama province, and in Al Jazira (northeastern 
Syria). The caper is adapted to dry heat and intense sunlight. Capparis spinosa L. is a valuable 
commodity for the resource poor nomadic communities living in the Syrian desert.While caper 
is widely cultivated in other Mediterranean countries, in Syria caper is a wild species and is 
cultivated only on an experimental level in research nurseries. Unlike in other countries, The 
caper buds, collected before the flowers have formed, are used in Syria as trade items. (Giuliani 
and Padulosi, 2005).  
 
 
Figure 1. The natural distribution of caper in the Eurasia and North Africa. Based on Inocencio 
et al. (2006) and Lin (2003).  
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3.1. PLANT DESCRIPTION: 
 
The caper Capparis spinosa L (fig. 2 ) is a perennial  lives 25 years spiny bush that bears 
rounded fleshy leaves and big (3-3.5 cm). polymorph shrub or climber armed with divaricate 
light yellow thorns, occurring in dry rocky.The flowers  white to pinkish-white.The bush is 
native to the Mediterranean region, growing wild on walls or in rocky coastal areas throughout. 
The plant is best known for the edible bud and fruit (caper berry) which are usually consumed 
pickled. Other species of Capparis are also picked along with C. spinosa for their buds or fruits 
( Inocencio et al.,2002;Fici,  , 2001 ; Al-Safadi et al.,2014). 
 
Botanical Name Capparis spinosa 
Kingdom: Plantae 
(unranked): Angiosperms 
(unranked): Eudicots 
(unranked): Rosids 
Order: Brassicales 
Family: Capparaceae 
Genus: Capparis 
Species  C.spinosa 
 
   Fig. 2. the Capparis spinosa plant 
Vernacular names:  
English:Caper,Caperberry,Caper 
bush. 
Finnish: Kapris.  
French:aprier,capres,fabagelle,tapana.  
German: Kapper, Kapernstrauch. 
Italian: Cappero,capperone(fruit). 
Marathi: Kabar. 
Spanish: Alcaparra,caparra,  
Arabic:l’Kabbar, Kabbar, Âssaf, 
Lasaf 
Shafalah (حلفشلا فصلوأ ربكلا)   
              Table .1 Capparis spinosa L.  plant classification ,Scientific Name and Common Name 
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Morphological features of root C. spinosa   
This shrub  has a high root/shoot ratio and the presence of  mycorrhizae serves to maximize the 
uptake of minerals  in poor soils. Different nitrogen-fixing bacterial strains have been isolated 
from the caper bush rhizosphere  playing a role in maintaining high reserves of that  growth-
limiting element. (Lam, Han et al. 2009).  Its roots are deep, Plants have been reported with 6-
10 m long roots (Reche Mármol, 1967; González Soler, 1973; Luna Lorente and Pérez Vicente, 
1985; Bounous and Barone, 1989). The root system may account for 65% of the total biomass 
(Singh et al. 1992).   
Root pieces are up to 5.5 cm in thickness; bark rough to touch, thick showing longitudinal 
lenticels; freshly broken surface light yellowish; wood hard and compact; remnants of robots 
and slender rootless present on the bark; color varies from pale yellow to reddish-brown;  odor 
of bud C. spinosa (e-Book government of india, 2008 ). 
A transverse section of root characterized by outermost layer of slightly submersed corky zone 
of several layers showing irregular and broken outline; cork cambium make of 4 or 5 layers of 
thin walled, small, squares cells; cortex consisting of thin walled, irregular or somewhat 
tangentially elongated cells; angular sclereids in groups of 2 to 3 and up to 30 µ in size 
scattered in cortex; phloem in the form of multiple layers of cells forming a continuous cylinder 
around inner vascular zone, separated from the xylem by 4 to 5 layers of vascular cambium; 
wedges of vascular isolated or in groups of two, distributed uniformly among xylem 
parenchyma, which has granular contents; medullary rays of thin walled, mostly uniseriate, 
rectangular cells, often having granular contents; pith absent Powder - Powder shows vessel 
fragments with simple pitted thickness and tracheids with tapering or blunt ends.  
(Anonymousn , 2000; e-Book government of india, 2008) 
 
3.2 Phytochemicals in caper  
 
Alkaloids 
The poly amine spermidine is analogue of diamine putrescine which is produced by reactive 
decarboxylation of lysin in microorganisms and animals (Cordell,1981). Several alkaloids 
contain spermidine joined with two cinnamic acid residue in any of the several ways for 
example lunarine, codonocarpine and pleurostyline (Cordell,1981).Structurally most interesting 
spermidine alkaloids are those having a macro cyclic ring. Typically, these compounds are 
formed by the condensation of one nitrogen with a carboxylic acid and the nucleophilic attack 
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of a second nitrogen on an electrophilic center with in the carboxylic contairing unit 
(Cordell,1981).Although the spermidine is found in microorganisms and animals, chore are 
some reports of its occurrence in higher plants (Smith,1970), mostly those used as food stuff 
including Brassica oleraeca (cabbage), Cycopersicum esculentum (tonatc)( Tabor H and Tabor 
C.W,1968), chorella (Kanazawa et al.,1997) aid in Petunia pollen(Linskens et al., 1968). There 
are some evidences that spermidine is found in Triticum sativum (wheat) and in the embroys of 
other cereals (Bagni et al., 1968) Spermidine along with spermine also occur (12:1 ratio) in 
human semen which are formed primarily in prostate glands and may be present for 
stabilization of DNA (Cordell,1981).  The presence of spermidine alkaloids like capparidisine, 
capparisine or capparisinine  and other in root bark of C. aphylla (Syn. Capparis decidua 
Edgew) and Capparis spinosa Table 02 .   
 Capparisin (molecular formula C26 H 31 N 3 O 5 ) has same skeletal system but one methoxy 
group less than capparisidine, capparisinine; it is an isomer of capparisidisine with a methoxy 
group at a different position. (Arif,1986).Recently, Yang et al. (2010) found that fruits of 
Capparis spinosa contain a significant amount of compounds with many health benefits. Three 
new alkaloids, (1) Capparisine A, (2)Capparisine B, (3) Capparisine C and (4) two known 
alkaloids, (4) 2-(5-hydroxymethyl-2-formylpyrrol-1-yl) propionic acid lactone and (5) N-(3'-
maleimidy1)-5-hydroxymethyl-2-pyrrole formaldehyde were isolated from the fruits of C. 
spinosa. 
Compound name 
and 
molecular weight 
Compound structure Cultivar Reference 
 
 
 
Spermidine 
alkaloid 
 
 
  
 
 
 
Cadabicine 26-O-
b-D-glucoside 
hydrochloride 
Mw 598 
 
 
 
root bark of 
Capparis 
spinosa 
Fu et 
al.2008 
47 
 
 
 
 
Capparispine 26-
O-b-D-glucoside 
Mw 598.27 
 
 
 
 
root bark of 
Capparis 
spinosa 
Fu et 
al.2008 
 
Isocodonocarpine 
Mw 465 
 
 
 
 
root bark of 
Capparis 
Decidua 
Ahmad et 
al. 1985 
Rathee et 
al., 2010; 
Chahlia, 
2009 
 
 
Cadabicine 
Mw 435.21 
 
 
 
root bark of 
Capparis 
Decidua 
root bark of 
Capparis 
spinosa 
Ahmad et 
al. 1987 
 
 
codonocarpine 
 
Mw 465.23 
 
 
 
root bark of 
Capparis 
Decidua 
Rathee et 
al., 2010; 
Mishra et 
al., 2007; 
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Capparidisine 
Mw 495 
 
 
 
root bark of 
Capparis 
Decidua 
Ahmad et 
al. 1992 
 
 
14-N- 
acetylcodonocarpi
ne 
C 28 H33 N3O6 
Mw 507 
 
 
root bark of 
Capparis 
Decidua 
Ahmed et 
al. 1987 
 
 
15- N- acetyl 
capparisine 
Mw 507 
 
 
root bark of 
Capparis 
Decidua 
Ahmed et 
al. 1987 
 
 
Capparisinine 
 
Mw 495.56 
 
root bark of 
Capparis 
Decidua 
Ahmed et 
al. 1987 
 
 
 
Capparisine 
 
Mw 465.22  
 
 
root bark of 
Capparis 
Decidua 
Gaind and 
Juneja, 
1970 
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Stachydrine 
Mw 144 
 
 
root bark of 
Capparis 
Decidua 
root bark of 
Capparis 
spinosa 
Arif, 1986 
L-Stachydrine 
Mw 
143.1836 
 
Capparis 
zeylanica 
Leaves 
root bark of 
Capparis 
Decidua 
Pradeep 
Singh 
et al.2011 
Windadri 
, 2001 
Rathee et 
al., 2010 
3-hydroxy 
stachydrine 
 
Mw 159,18 
 
 
Capparis 
zeylanica 
leaves 
Pradeep 
Singh 
et al.2011 
 
Windadri, 
2001 
 
β-Sitosterol 
C59H106O2 
Mw 846  
 
root bark of 
Capparis 
Decidua 
Rathee et 
al., 2010 
Table 2. The presence of spermidine alkaloids and other compound in capparis .sp   
 
3.3 Pharmacological studies 
Antiviral and immunomodulatory effect of a lyophilized extract of Capparis spinosa L. buds. 
Herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV- 2) are  common  
human  pathogens  that  in  particular cases  can  also  cause  severe problems especially in 
immunodeficient patients. The present paper reports the antiviral and immunomodulatory 
properties of a methanolic extract of C. spinosa buds (CAP), rich in flavonoids, including 
several quercetin and kaempferol glycosides. In particular we have investigated whether the in 
vitro exposure of human peripheral blood mononuclear cells (PBMCs) to CAP might inhibit 
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the replication of HSV-2 and modulate the induction kinetics of IL-12, TNF-alpha IFN-gamma. 
Our findings have shown that CAP treatment interferes with HSV-2 replication in PBMCs 
inhibiting the extra cellular virus release up regulating their production of IL-12, IFN-gamma 
and TNF-alpha. One could speculate that CAP may contribute in improving immune 
surveillance of PBMCs toward virus infection by up-regulating expression of peculiar 
proinflammator cytokines; it should thus be successfully employed for treatment of HSV-2 
infections in immunocompromised hosts. (Arena et al., 2008 ) 
 
Effect  of  Capparis  spinosa  on  fibroblast  proliferation  and  type  I  collagen production in 
progressive systemic sclerosis.  
The effects of ethanolic extract from Capparis spinosa (ECS) on the fibroblast proliferation and 
type I collagen production in  normal and progressive  systemic sclerosis (PSS). METHOD: 
Cellular activity was determined by the MTT method. Apoptosis was detected by flow 
cytometry analysis of Annexin V-Stained cells. The expression levels of type I collagen 
messenger RNA and protein were analyzed by proliferation of fibroblast and reduced the 
expression of alpha2 (I) collagen mRNA and type I collagen protein in PSS in a dose-and time-
dependent manner. ECS did not affect the proliferation of fibroblast and expression of type I 
collaged mRNA and protein in normal human. ECS could counteract the harmful effects on 
fibroblast by H202. conclusion: ECS can effectively inhibit the fibroblast proliferation and type 
I collagen production in PSS. (Cao et al., 2008). 
 
Protective effect of Capparis spinosa on chondrocytes.  
The in vitro chondroprotective effects of the lyophilized methanolic extract from flowering 
buds of Capparis Spinosa L (LECS). This plant, common to the Mediterranean basin, has been 
used by the traditional medicine for its diuretic and antihypertensive effects and also in certain 
pathological conditions related to uncontrolled lipid per oxidation. The extract contains many 
constituents, in particular some flavonoids (kaempferol and quercetin derivatives) and 
hydrocinammic acids with several known biological effects such as the anti-inflammatory and 
the antioxidant ones. In this study, we assayed the effect of LECS on human chondrocytes 
cultures stimulated by proinflammatory cytokine interleukin-1beta (IL- 1beta) and we 
determined the production of key molecules released during chronic inflammatory events 
(nitric oxide, glycosaminoglycans, prostaglandins and reactive oxygen species). We observed 
that LECS was able to counteract the harmful effects induced by IL-1beta. This protection 
appeared to be greater than that elicited induced by IL-1beta. This protection appeared to be 
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greater than that elicited by indomethacin, which is usually employed in joint diseases. Since 
LECS possess a chondroprotective effect,  it  might  be  used  in  the  management  of  cartilage  
damage  during  the inflammatory processes.(Panico et al, 2005). 
  
Hypolipidemic activity of aqueous of Capparis spinosa L. in normal and diabetic rats   
The effect of single and repeated oral administrations of the aqueous extract of Capparis 
spinosa L. (CS) at a dose of 20mg/kg on lipid metabolism in normal and streptozotocin – 
induced diabetic on plasma triglycerides concentrations 1 week (p<0.05).We conclude that the 
aqueous extract of CS (20 mg/kg) exhibits a potent oral administration of CS aqueous extract. 
(Eddouks et al. 2005) . 
 
Antiallegic  and  antihistaminic  effect  of  two  extracts  of  Capparis  spinosa  L. flowering 
buds. 
The antiallergic properties of two lyophilized extracts obtained from Capparis spinosa L. 
flowering buds (capers) by methanol extraction, carried out at room temperature (CAP-C) or 
with heating at 60 degrees C (CAP-H), were investigated. The protective effects of CAP-H and 
CAP-C, orally administered (14.28 mg[sol] kg), were evaluated against Oleaceae antigen 
challenge-induced and histamine-induced brochospasm in anaesthetized guinea-pigs. 
Furthermore, the histamine skin prick test was performed on humans, applying a gel 
formulation containing 2% CAP-C (the only extract able to protect against histamine-induced 
bronchospasm) on the sin for 1 h before histamine application and monitoring the erythema by 
reflectance spectrophotometer. The CAP-H showed a good protective effect against the 
bronchospasm induced by antigen challenge in sensitized guinea-pigs; conversely, a significant 
decrease in the responsiveness to histamine was seen only in CAP-C pretreated animals. 
Finally, the CAP-C gel formulation possessed a marked inhibitory effect (46.07%) against 
histamine – induced skin erythema. These two caper extracts displayed marked antiallergic 
effectiveness; however, the protective effect of CAP-H was very likely due to an indirect 
mechanism (for example, inhibition of mediator release from mast cells or production of 
arachidonic acid metabolites); conversely, CAP-C is endowed with direct antihistaminic 
properties. The different mechanisms of action of CAP-H and qualitative, quantitative chemical 
profile (Trombetta et al. 2005). 
 
Antihepatotoxic activity  
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P-Methoxy benzoic acid isolated from the methanolic soluble fraction of the aqueous extract of 
Capparis spinosa was found to posses’ significant antihepatotoxic activity against carbon 
tetrachloride – and paracetamol-induced hepatotoxicity in vivo hepatocytes, using in vitro 
technique. (Gadgoli and Mishra ,1999).  
Anti-inflammatory activity  
The extract of Capparis spinosa contains many constituents, in particular some flavonoids 
(kaempfefol and quercetin derivatives) and hydrocinammic acids with several known biological 
effects such as anti-inflammatory and antioxidants effects.(Lam et al. 2009) Capparis  spinosa  
was  found  to  posses  significant  anti-inflammatory activity against carrageenan-induced 
oedema in rats (Ageel et al. 1986)   
 
Anti-hyperglycaemic activity in  rats  
Capparis spinosa also possesses anti-hyperglycemic and hypolipidemic activities. The 
aqueous extract of powdered fruits C.s   exhibits a potent antihyperglycemic activity without 
affecting basal plasma insulin concentrations. (Eddouks et al. 2004)It also exhibits a potent 
lipid lowering activity in both normal and severe hyperglycemic conditions after repeated 
oral administration of the extract. 
Capparis spinosa is one of the constituents of the  hepatoprotective formulation “Liv.52” 
administered to treat preliminary cases of acute viral hepatitis and cirrhosis of liver. It has 
also shown encouraging results against viral infection in man. The beneficial effects of 
Capparis spinosa on liver can be attributed to its potent antioxidant,antimicrobial  
,immunomodulating  and anti-inflammatory activities. (Eddouks et al.2005; Arena et al., 2008 )
  
 
 
Antimicrobial properties of C. spinosa roots  
Ethanol, methanol and ethyl acetate root extracts exhibited higher antimicrobial activity than 
fruit extracts. Fruit ethanolic extract had higher activity against strain of Streptococcus sp. and 
Gram-negative bacteria. Thus, fruits and roots of C. spinosa can be traditionally used for 
treatment of bacterial infection in hemorrhoids and diarrhea. Antioxidant components other than 
phenolics play critical role in its antimicrobial activity (Mahboubi. M and Mahboubi. A 2014). 
A decoction from root of Capparis spinosa L. has shown a good antibacterial activity inhibiting 
the growth of Deinococcus radiophilus (Boga et al, 2011). The aerial parts of Capparis spinosa 
have shown a very good antimicrobial activity against gram-positive and gram-negative 
bacteria, and also moderate to good antifungal activity against C. albicans and A. flavus 
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(Mahasneh, 2002). A decoction from root of Capparis spinosa L. has a very good antibacterial 
activity on the growth of Deinococcus radiophilus (Boga et al.,2011).  
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Abstract  
 
Over the past decade, pomegranate (Punica granatum) is entitled as a wonder fruit because of its 
numerous pharmacological properties and the recent global trend of increased demand for 
pomegranates, whether as fresh fruit or as derived products, is growing. Well known countries 
producers of pomegranates are Iran, Turkey, Egypt, Italy and Syria Pomegranate (Punica granatum 
L.) has been extensively studied and the fruit is well known in folk medicine of several 
countries. Last decade there has been a dramatic increase of interest in pomegranate as a 
medicinal and nutritional product due to its newly identified potential health effects, which 
include treatment and prevention of cancer and cardiovascular diseases. Pomegranate exocarp 
and mesocarp are usually discarded as waste during the juice extraction even could be good 
sources of bioactive compounds. In this study two cvs, Laffan from Syria and Wonderful  from 
Italy have been selected with the aim to investigate on their composition in terms of 
ellagitannin content. For the extraction only water and ethanol have been selected as solvent 
suitable for food uses. A quick and efficient HPLC/DAD method was then applied to quantify 
and compare the different extracts in terms of ellagitannins (HTs) particularly punicalagins and 
ellagic acid derivates. 
The results elucidated the differences in terms of different content of  HTs between exocarp 
and mesocarp, highlighting  higher amount of these molecules in mesocarp. The α+ β 
punicalagins ranged from 66-80 % of the total content, ellagic acid and its derivatives 
(hexoside, rhamnoside and pentoside) ranged from 4.5 % to 9.6 for  mesocarp and exocarp. 
Overall these wastes could be a suitable source of interesting amount of ellagitannins. 
 
 
 
Keywords: tannins, punicalagin, ellagic acid, decoction, bioactive compounds 
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Introduction 
 
Over the past decade, pomegranate (Punica granatum) is entitled as a wonder fruit because of 
its numerous pharmacological properties and the recent global trend of increased demand for 
pomegranates, whether as fresh fruit or as derived products, is growing. The global production 
and trade of pomegranates and the fruit's derivatives need to be improved mainly due to the 
garden character of production in the leading producing countries, India, China and Iran 
(Rymon, 2011). Pomegranate is cultivated around the world in subtropical and tropical regions 
with different microclimate. Well known countries producers of pomegranates are Iran, Turkey, 
Egypt, Italy and Syria. Iran contributed to at least half of the total world production (more then 
700.000 tons/years; FAOSTAT, FAO 2010). Trading has grown steadily in last years, according 
to a greater awareness of consumers about potential health benefits. 
The pomegranate has been widely investigated and several recent publications confirm this 
fruit as a powerful source of bioactive metabolites. According to literature demonstrating the 
health effects of this fruit, pomegranate represents a typical nutraceutical product to be included 
in human diet  
Punicalagins, the main ellagitannins of pomegranate have shown to possess remarkable anti-
inflammatory and anti-genotoxic properties (Chen et al., 2003; Kulkarni et al., 2007). 
Ellagic acid, a minor constituent of pomegranate fruit, showed also antioxidant, anticancer and 
anti-atherosclerotic activities (Seeram et al., 2004).  
Significant efforts have been made to define the individual active components and the 
pharmacological properties of peel (pericarp or rind); since 1830 in the United States 
Pharmacopeia and in the Philadelphia edition the use of the rind of pomegranate was reported. 
This part of the fruit is often discarded as waste even if it has shown potent biological activities 
(Hajimahmoodi et al., 2008; Gözlekçi et al., 2011). A recent review has provided an insight on 
the phytochemical components that contribute to antihyperglycemic, hepatoprotective, 
antihyperlipidemic effects  of the pomegranate peel extracts (Middha et al, 2013).  
The tannin-rich peels as byproducts of food industry are recently used in animal feeds in many 
developed countries such as USA. An interesting antimicrobial activity of pomegranate peel 
has been demonstrated against several pathogenic bacteria (Reddy et al., 2007; McCarrell et 
al., 2008).  
According to the botanical classification, the husk of pomegranate fruit is constituted of two 
main parts: the exocarp (as cuticle layer) and the mesocarp known also as albedo, the spongy 
tissue and wall where the arils are attached. The multi-ovule chambers (locules) are separated 
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by a membranous walls (septum) from the mesocarp (Fahan, 1976). Nevertheless, in literature 
lacking data are available on the composition of the different parts of this fruit particularly of 
the mesocarp, usually discharged during the juice production. To date in the published works 
the botanical structure of this fruit is not so clearly defined; for example the peel has several 
synonymous as skin, rind, husk, and hull and it is often not distinguished by the mesocarp 
(Seeram et al.,2005; Zhou et al., 2008; McCarrell et al., 2008 ;Cuccioloni  et al. 2009;Çam and 
Hısıl 2010; Romani et al., 2012; Lu et al., 2008;Saad et al.,2012).Few years ago some authors 
reported that the peel or rind constitutes about 45-50% of the total weight of the fruit (Al-Said 
et al., 2009; Levin, 2006). This appears as an evident mistake from the botanical point of view 
because presumably the authors with the term peel have taken into account also the mesocarp. 
To the best of our knowledge, only in a recent work focused to study the constituents of the 
different parts of a Peruvian pomegranate is specifically cited the composition of the mesocarp 
(Fischer et al., 2011). 
Even if the juice composition of pomegranate has been widely investigated, no data are 
available on the fruit of the Laffan variety, a typical cultivar cultivated in Syria. The Laffan 
variety (named also Red Loufani, or Lefan) has been described as a sour-sweet flavour fruit, 
large size with yellow skin, large arils, a sweet-sour flavor, and very hard seeds (Ozguven and 
Yilmaz 2000; Ozguven et al., 2006). It is a local strain from Syria particularly of Idlib (north of 
Syria), Palestine and Israel (Morton, 1987) and one of the main variety cultivated in Hatay, 
Turkey. 
The Wonderful variety grows extensively in California, and it has become worldwide popular 
to produce from arils the commercial juice well known for its potential health benefits (Lansky 
and Newman , 2007;  ). Several papers report data on juice composition of this variety (Mena et 
al., 2012), on findings related to its pleasant sensorial properties (Vázquez-Araújo et al., 2011), 
on HPLC/DAD/MS analysis of juice obtained by squeezing out of the whole fruits cultivated in 
Spain (Sentandreu et al., 2013).  
Wonderful Pomegranate is used to obtain a standardized extracts named POMx obtained by the 
extraction of arils and peel and recently tested to reduce the prostate oxidative stress (Freedland 
et al., 2013). According to some authors (Goor,1967), these two cvs, Laffan and Wonderful, 
seem to have several similarities with fruits very like one another in appearance, both are late 
ripening, with a rather sour and excellent organoleptic qualities. 
Regarding chemical composition several data are available on the pomegranate peel where 
tannins are the main secondary metabolites, usually divided into two major groups the 
Hydrolysable Tannins (HTs) and the Condensed Tannins (CTs) (Hassanpour et al., 2011a, 
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2011b); the HTs are mainly located in the fruit peel and mesocarp (Gil et al., 2000; Fischer et 
al., 2011) with α and β punicalagins as predominant HTs (Haslam, 2007; Fischer et al., 2011; 
Romani et al., 2012; Çam and Hışıl, 2010; Lu et al., 2008). 
Ellagic acid and some ellagic acid derivatives (ellagic acid hexoside, -pentoside, etc.) are also 
present, although in lesser amounts (Cerda et al., 2003b; Seeram et al., 2005; Fischer et al., 
2012). In addition to ETs, pomegranate peel contains cyanidin, pelargonidin, and delphinidin 
(Noda et al., 2002) and flavonoids as kaempferol, luteolin, and quercetin (Van Elswijk et al., 
2004). The presence of alkaloids (e.g., pelletierine) in the peel is equivocal positive by 
Dragendorff assay, but negative by Mayer assay (Vidal et al., 2003). 
The aim of the work is to investigate on the discharge parts, mesocarp and exocarp of 
pomegranate fruits from the two varieties Laffan and Wonderful. To this aim all samples 
derived by water extractions have been treated to precipitate the crude polysaccharide. Overall, 
for the extraction only water and ethanol have been selected. A quick and efficient HPLC/DAD 
method was then applied to quantify and compare the different extracts in terms of HTs 
content. The quantitative data have been focused to ellagitannins as main constituents, 
particularly punicalagins and ellagic acid derivates. The work helps to clarify the composition 
in terms of HTs of the Laffan cv, a low investigated cultivar, compared to Wonderful cv, a well 
known commercial variety. To date, only scant data are specifically available on the tannin 
content of mesocarp and peel of these two varieties and our results can contribute to improve 
the value of these by-products. 
 
Experimental Part  
Plant materials  
Fresh ripe fruits (about 5 kg of Laffan and 20 Kg of Wonderful) from two pomegranate 
cultivars were analysed. The Laffan cv (sour-sweet) was from Rif Idlib, Syria harvested in 
October 2011 and identified by a member of General Commission for Scientific Agricultural 
Research (Syria); the Wonderful cv was purchased from Ortofrutta Grosseto (Italy) in October 
2013.  
 
Standard and solvents  
Ellagic acid purity ≥95%, α, and β punicalagins purity ≥98% were purchased from sigma 
Aldrich. All solvents (HPLC grade) and formic acid (ACS reagent) were purchased from 
Aldrich Company Inc. (Milwaukee, Wisconsin, USA).  
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Sample preparations 
Arils, peels and mesocarp were manually separated from fresh pomegranates, then washed with 
water separately. The fresh peel and mesocarp were freeze dried after cut into small pieces. 
Both vegetal parts were powdered in a grinder immediately before the extraction applying the 
methods described below. For all the extracts the applied drug/solvent ratio was 1:40 w/v 
starting always from the dried powdered material.  
 
Extraction processes  
Ethanol-water extraction. A hydro alcoholic treatment was applied using ethanol 70 % (v/v) 
stirring at room temperature for 24h. The extracts were then filtered through Whatman filter 
paper to remove solid residue.  
Hot water extraction. The dried powdered material was boiled in distilled water stirring for 1 h 
obtaining Dec1. After cooling and centrifugation at 4500 rpm for 8’ at 4 °C to collect the 
supernatant the same procedure was applied on the solid residue (Dec2). The supernatants were 
then treated with 2 volumes of ethanol and kept for 3 h at 0 °C for precipitation of crude 
polysaccharides. Then the solutions were centrifuged at 4500 rpm for 12 min to remove 
polysaccharide fraction. 
Water extraction at room temperature. The dried powdered material was soaked in distilled 
water stirring for 24 hours. To remove the polysaccharides was applied the same procedure of 
the hot water extraction.  
Finally, all the extracts were dried under vacuum at 30°C, then redissolved in a mixture of 
EtOH:H2O (7:3 v/v) and centrifuged at 14.000 rpm, for 2’, before HPLC/DAD analysis.  
 
HPLC-DAD analyses  
The analyses were carried out using a HP 1100L liquid chromatography equipped with a DAD 
detector (Agilent Technologies, Palo Alto, CA, USA). A 150mm×2 mm i.d., 4μm, Fusion RP 
80 A, column (Phenomenex, USA) equipped with a precolumn of the same phase was used. 
The mobile phases were (A) 0.1% formic acid/water and (B) CH3CN. The multi-step linear 
solvent gradient used was: 0-4 min 5–25% B; 4–8 min, 25–25% B; 8–14 min 25–35% B; 14–
16 min 35–90% B with a final plateau of 2 min at 5%B; equilibration time 10 min; flow rate 
0.4 mL min
-1
 and oven temperature 26 ◦C. The UV-Vis spectra were recorded in the range 
200–500 nm and the chromatograms were acquired at 240 nm, 350 nm, 370 nm, 380 nm.  
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Quantitative evaluation of tannins  
The quantitative evaluation of the main constituents was performed using two external 
standards: the α+β punicalagins at 380 nm and ellagic acid at 370 nm. The first compound was 
used at 380 nm to quantify α, β punicalagins and derivatives, while the second one at 370 nm to 
determine ellagic acid and derivatives.  
Stock solution of α+β punicalagins, 1mg/mL, was prepared in DMSO and then diluted with 
H2O before the HPLC analyses; solution of ellagic acid 0.78 mg/mL was prepared in MeOH. 
The calibration curve of α, β punicalagins was in a linearity range between 0.5 μg and 8 μg 
with a R² =  0,9982; the calibration curve of ellagic acid was in the linearity range of 0,031–
1,25 μg with R² = 0,9995.  
 
Results and Discussion 
 
Mesocarp and exocarp composition 
First aim of the work was to perform a qualitative evaluation of ellagitannins content in discard 
materials from pomegranate fruit. These compounds have been chosen as target molecules of 
this study because recognized as the main phenols of pomegranate fruit (Fischer et al., 2012; 
Romani et al., 2012; Çam and Hışıl, 2010; Lu et al., 2008). Mesocarp and Exocarp, as by-
products from pomegranate juice production, are very cheap material but can be interesting 
sources of polyphenols, mainly ellagitannins. Two different cultivars (Laffan from Syria and 
Wonderful from Tuscany) were compared in order to investigate on the ellagitannins content. 
An hydro alcoholic mixture (70:30 EtOH:H2O v/v) was firstly selected as common procedure 
for extraction of polar compound from different vegetal materials and then water was chosen as 
cheap and green solvent for the ellagitannin recovery. The decoction of fruit discards has also 
reported as domestic method to prepare pomegranate extracts used in the traditional Syrian 
medicine (Ibn al-Baytar, 1874). According to this tradition, decoction was applied but also a 
water extraction at room temperature was tested for both the exocarp and the mesocarp. Some 
authors reported the water as not effective solvent for the extraction of tannins from 
pomegranate peels compared to methanol (Çam and Hışıl, 2010; Elfalleh et al., 2012). These 
authors did not taken into account that the dried extracts obtained from water extraction 
certainly include the hygroscopic polysaccharides. This induces to apply further treatment (see 
experimental) to precipitate and separate this fraction and to have a cleaner extract mainly 
constituted by polyphenols. Again, the highest total phenolic amount was observed with 
methanol, followed by water then by ethanol, while the lowest value was with ethyl acetate 
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(Wang et al., 2011). On the opposite, other authors report that water extracts were the most 
efficient to recover the polyphenols from the dried peel obtaining up to 18% on dried weight, 
followed by ethanol 50%( v/v) with a 16% on dried material (Wissamet al., 2012).  
First, ellagitannins identification was carried out working on the hydro alcoholic sample from 
pomegranate peel by applying an HPLC/DAD method previously described (Romani et al., 
2012). Successively a shorter analytical method performed using a new generation column 
(RP18 Synergi Fusion) was developed to reduce time of analysis and to improve resolution. 
The retention times of -punicalagin, -punicalagin and ellagic acid at 5,76, 6,23, and 8,49 min 
respectively were in agreement with the polarity sequences but significantly shorter than those 
reported in previous procedures (Seeram et al., 2004; Lu et al. 2008; Romani et al., 2012). 
Overall the optimized HPLC/DAD method proposed requires half time of the analysis in 
comparison with other cited methods.  
The rt values, the use of specific standards (alfa+beta punicalagins, ellagic acid) and the UV-
Vis spectra allowed to characterize the main components of the various extracts (Figure 1).  
 
 
 
Figure 1: UV-Vis spectra of α + β punicalagins  (A) and ellagic acid hexoside, ellagic acid 
pentoside and ellagic acid(B) 
 
This optimised analytical procedure was applied also for the sample from mesocarp. 
According to the previous works, five main molecules were identified: α+β punicalagins, 
ellagic acid hexoside, ellagic acid pentoside and ellagic acid, while other components were 
recognized as minor tannins (Figures 3a and 3b).  
In Figure 2 are reported the chemical structure of the main bioactive compounds present in all 
the analysed samples. 
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Figure 2: Chemical structure of ellagic acid (A) α+ β punicalagins (B) 
 
The Figure 3a and 3b compares the chromatographic profiles at 370 nm of three extracts from 
mesocarp and peel of Laffan cv; the corresponding profiles of Wonderful cv are not shown 
because very similar. 
 
 
 
 
 
A:  ellagic acid 
b:  α+β punicalagins 
 
A 
B 
a) 
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Figure  3: Chromatograms at 370 nm of three different(A, B, C)  extracts from mesocarp (3a) 
and  from exocarp (3b). 1) α-punicalagin, 2) β-punicalagin, 3) ellagic acid hexoside, 4) ellagic 
acid pentoside, 5) ellagic acid. 
 
A comparison among the chromatographic profiles obtained from the three procedures (Figure 
3a and 3b) did not show relevant qualitative differences. Both in mesocarp and exocarp the 
same components have been revealed, even if with different relative amounts as discussed in 
the next paragraph. All these solvents were able to extract the main polyphenols from both 
materials and most significant remarks are related to water extraction. Our results in agreement 
with previous work (Romani et al., 2012), demonstrate ellagitannins of pomegranate did not 
degrade even after a long boiling processes. Moreover the water at room temperature is able to 
efficiently recover the ellagic tannins from these by-products maintaining almost the same 
relative abundance (see next paragraphs). 
 
Quantitative Results  
The ellagitannins content in terms of α+ β punicalagins as most abundant compounds, ellagic 
acid and its glycosides as minor components, was evaluated in all the different extracts.  
Comparing the data related to dried material (mg/g DM) of mesocarp for the two cvs, (Figure 
4A), it has been observed a comparable amounts both in terms of total tannins (close to 120 
b) 
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mg/g) and of each compounds. As expected, the α+β punicalagins resulted the main compounds 
reaching the 66- 80 % of the total tannins in all the extracts of mesocarp. 
All data reported in histograms of Figure 4 are only related to the first step of decoction (Dec1) 
of both mesocarp and exocarp. Indeed the quantitative evaluation performed on Dec2 have 
highlighted a very low recovery of ellagitannins, about one order of magnitude lower than 
those obtained from only the Dec1 with values for mesocarp of 10,68 ± 2,28 mg/g DM for 
Laffan and 13,76 ± 0,33 mg/g DM for Wonderful. The exocarp showed lower recoveries: from 
8,92 ± 0,48 for Wonderful to 11,65 ± 0,83 for Laffan. According to these results it can be 
assessed that a single step of decoction is able to extract almost all the ellagitannins from the 
two by-products. 
It is known that water is a efficient solvent for polysaccharides extraction from herbal matrices, 
especially in high temperature treatments as the decoction. Nevertheless, to date only few data 
can be found on the polysaccharide content of pomegranate (Zhu and Liu, 2013). According to 
that consideration all aqueous extracts were processed (see experimental section) to remove the 
polysaccharides before the HPLC/DAD analyses. A detailed study on these components (see 
fifth chapter of this thesis) have pointed out the crude polysaccharides recovered from 
mesocarp were close to 10% of the dried weight while a lower amount (5 %) was in the dried 
peel.  
The process was not required for the hydro-alcoholic extract because the high percentage of 
ethanol don’t allow their solubilization in the sample. Moreover, it is a common and widely 
applied procedure to add ethanol in a ratio of 2:1 v/v up to 4:1 v/v to precipitate the 
polysaccharides from water samples (Joseph et al., 2013; Jahfar et al., 2003).  
Comparing the decoction and the aqueous extract at room temperature from mesocarp (Figure 
4A)  it can be observed that both the cvs show a very similar content of total tannins, around 
100 mg/g DM. The α+ β punicalagins, as already seen for the hydro alcoholic extracts, are the 
main compounds, reaching 66-67% of the total ellagitannins for the decoction and 74-78% for 
the aqueous extract at room temperature.  
Regarding ellagic acid and its derivatives content in mesocarp, obtained amounts are shown in 
Table 1. Their content ranged between 4,4 -7.1 % of the total ellagitannin of mesocarp; due to 
the less polarity of these molecules if compared with the punicalagins, for both cvs a higher 
extractive efficiency was observed using the hydro alcoholic mixture compared with the water 
samples. A pomegranate acidified methanol extract (80% v/v) from mesocarp of a Peruvian 
fruit (Fischer et al., 2012 ) showed an amount of 40,59 mg /g of total ellagitannins, 0,23 mg/g 
of ellagic acid and 0,5 mg/g of ellagic acid hexoside plus pentoside. The higher amount 
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obtained in our extracts can be attributable to a longer extraction time and a more exhaustive 
recovery with respect to the Fisher’s work in which the extraction time was only of 30 min.  
 
Table 1: Content of ellagic acid and its derivatives (mg/g DM) in the three different extracts obtained 
from mesocarp; the data are a mean of triplicate of each extraction. 
 
Regarding the exocarp, again a similar trend for the two cvs, was observed, although the total 
tannins content with respect to the DM was lower than in mesocarp with 77.50 mg/g for Laffan 
and 92.24 mg/g for Wonderful. Again, in this part of the fruit, α+ β punicalagins represent the 
major compounds reaching 61-76% of the total tannins. As shown in Figure 4B the peel 
contains the same tannins detected in the mesocarp but in lower concentration. 
Analyzing more than 16 peel pomegranate varieties extracted with ethanol 40 % and 
determined by HPLC, the amounts of  total punicalagins were from 45-121 mg/g DM (Lu et 
al., 2008); other authors  reported  up to 116,6 ± 12,2 mg/g  α+ β-punicalagins on DM from 
pomegranate peels extract obtained with pressurized water (Çam and Hışıl, 2010 ) . 
A recent study (Gözlekçi et al., 2011) has evaluated the phenolic content in different parts of 
the fruit from four Turkish pomegranate cultivars and among these, also the Laffan cv was 
evaluated. Only a value of 3547 mg/L of total phenols has been reported in this work and the 
data was related not to dried matrix but to a ethanol/water extract (obtained with a final 
concentration of 1g dried peel /50 mL solution). Nevertheless these authors used the Folin–
Ciocalteu colorimetric method, therefore  a comparison with our results from HPLC-DAD is 
not possible. 
Overall, from our data, ellagic acid and its derivatives in exocarp range between 3,4-8,9 % of 
the total ellagitannin; for both the cvs an higher extractive efficiency was reached using the 
hydro alcoholic mixture compared with the use of water alone (Table 2). 
 
Method cultivar 
ellagic ac 
hexoside 
ellagic ac 
pentoside 
ellagic ac 
ellagic ac and  
der 
Decoction  
Laffan  2,71±0,22 1,49± 0,07 3,10±0,33 7,30±0,62 
Wonderful  2,28±0,08 1,28±0,04 2,08±0,26 5,63±0,34 
Water  
(room temp) 
Laffan  2,17±0,026 0,89±0,04 1,70±0,7 4,76±0,45 
Wonderful  2,37±0,21 0,68±0,02 1,55±0,21 4,60±0,44 
Ethanol  
70 % v/v 
Laffan  2,76±0,16 1,34±0,12 2,10±0,22 6,19±0,44 
Wonderful  3,44±0,07 1,73±0,27 2,05±0,02 7,22±0,36 
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Methods Sample ellagic acid 
hexoside 
ellagic acid 
pentoside 
ellagic acid ellagic acid + 
derivatives 
Decoction 
Laffan 1,64±0,10 1,54±0,06 2,73±0,16 5,63±0,20 
Wonderful 2,32±0,03 2,07±0,03 2,80±0,07 7,19±0,17 
Water 
(room temp.) 
Laffan 1,11±0,01 1,04±0,02 2,36±0,18 4,51±0,14 
Wonderful 1,10±0,0 0,72±0,04 1,61±0,03 3,43±0,02 
Ethanol 
70 % v/v 
Laffan 2,03±0,09 1,78±0,12 1,92±0,14 5,72±0,29 
Wonderful 2,86±0,23 2,89±0,16 3,14±0,29 8,89±0,67 
 
Table 2: Content of ellagic acid and its derivatives (mg/g DM) in the three different extracts obtained 
from exocarp; the data are a mean of triplicate of each extraction. 
 
A study carried out using water as solvent at elevated pressures (Çam and Hışıl,2010) showed 
the ellagic acid content only of 1,25 ± 0.2 mg/g DM, and similar values for its derivatives 
(0,83-1,21 mg/g DM). These lower values were attributable to the low solubility of ellagic acid 
in this media compared to methanol which is used as extraction solvent in other studies. The 
maximum concentration of ellagic acid (10,8 mg/g DM) was for rind of Punica granatum 
Gansu Province (China) refluxed  by  methanol 50 %  (Zhou et al., 2008). Recently, Fisher 
(2012) found similar content in peel of a Peruvian fruit with 0,64 mg/g ellagic acid and up to 
0,97 mg/g  or ellagic acid-hexoside.  
  
B 
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Figure 4: Comparison among total ellagitannins, punicalagines, ellagic acid and its 
derivatives (mg/g of DM) for different extracts of mesocarp (A) and exocarp (B) from Laffan 
and Wonderful pomegranate cvs. Mean data carried out from extraction in triplicate.  
 
It has been reported that -punicalagin and -punicalagin interconvert each-other with an 
equilibrium constant (K = []) of 1 in methanol and 4 in water (Doig et al., 1990). 
Nevertheless  other authors reported a ratio of 1,60 in 40% of ethanol (Lu et al., 2008) and 
underlined this ratio will not change with changing  of solvent.  Our results summarized in 
Table 3, pointed out that this ratio is very similar for peel and mesocarp of these cvs, the values 
ranged between 1,21 to 1,40 and it is not influenced by the use of water or ethanol 70 %.  
A 
B 
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mg/g DM 
 Extraction 
procedures 
Part of the fruit -punical -punical 
Ratio 
[] 
Decoction  
LM  28,50 36,13 1,27 
WM 28,11 39,25 1,40 
LE 19,73 27,36 1,39 
LE 21,51 27,98 1,30 
Water 
(room temp) 
LM 36,09 47,83 1,33 
WM 27,94 39,55 1,42 
LE 15,02 18,67 1,24 
WE 13,59 16,46 1,21 
Ethanol  
70 % v/v 
LM 40,19 53,17 1,32 
WM 37,89 51,12 1,35 
LE 23,60 31,51 1,34 
WE 26,27 35,41 1,35 
 
Table 3. Ratios [] punicalagins obtained by the yields values (mg/g of dried matter) for exocarp 
and mesocarp of the two cvs in water and ethanol 70% v/v. LM: Laffan Mesocarp;WM: Wonderful 
Mesocarp; LE: Laffan Exocarp; WE: Wonderful Exocarp. 
 
As it can be easily observed by Figure 5 for the mesocarp, the different extracts for the two 
considered cvs, showed a very similar content of total tannins, around 140 mg/g DE. This data 
confirm that the use of hydro alcoholic mixture is not able to extract the polysaccharide 
fraction. 
Regarding the exocarp an higher variability of the quantitative data was evidenced, probably 
due to the non homogeneous lyophilized material Figure.5B  
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Figure 5: Quality of the extracts for different extracts of mesocarp and exocarp from Laffan 
and Wonderful pomegranate cvs. Mean data from extraction carried out in triplicate. 
  
0,00 
20,00 
40,00 
60,00 
80,00 
100,00 
120,00 
140,00 
160,00 
D
ec
o
ct
io
n
  
Et
O
H
/H
2
O
+ 
H
2
O
 
D
ec
o
ct
io
n
  
Et
O
H
/H
2
O
+ 
H
2
O
 
Laffan Wonderful 
Mesocarp  
(mg/g DE) 
minor tannins 
 ellagic acid +der  
a+b punicalagine 
0,00 
50,00 
100,00 
150,00 
200,00 
D
ec
o
ct
io
n
  
Et
O
H
/H
2
O
+ 
H
2
O
 
D
ec
o
ct
io
n
  
Et
O
H
/H
2
O
+ 
H
2
O
 
Laffan Wonderful 
Exocarp 
(mg/g DE) 
minor tannins 
 ellagic acid +der  
a+b punicalagine 
A 
B 
73 
 
References   
 
Al-Said, F.A., L.U. Opara and R.A. Al-Yahyai. (2009). Physico-chemical and textural quality 
attributes of pomegranate cultivars (Punica granatum L.) grown in the Sultanate of Oman, J 
Food Eng, 90: 129-134 
Çam, Mustafa, and Yaşar Hışıl. (2010). "Pressurised water extraction of polyphenols from 
pomegranate peels." Food Chemistry,123(3) ,878-885. 
Cerda, B., Ceron, J. J., Tomas-Barberan, F. A., & Espin, J. C. (2003b). Repeated oral 
administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is 
not toxic. Journal of Agricultural and Food Chemistry, 51,3493–3501. 
Chen, T., Yang, I., Irby, R., Shain, K. H., Wang, H. G., Quackenbush, J., & Yeatman, T. J. 
(2003). Regulation of caspase expression and apoptosis by adenomatous polyposis coli. Cancer 
research, 63(15), 4368-4374. 
Cuccioloni, M., Mozzicafreddo, M., Sparapani, L., Spina, M., Eleuteri, A. M., Fioretti, E., & 
Angeletti, M. (2009). Pomegranate fruit components modulate human thrombin. Fitoterapia, 
80(5), 301-305. 
Elfalleh, W., Hannachi, H., Tlili, N., Yahia, Y., Nasri, N., & Ferchichi, A. (2012). Total 
phenolic contents and antioxidant activities of pomegranate peel, seed, leaf and flower. J Med 
Plants Res, 6, 4724-4730. 
Fahan, A., 1976. The leaf, the flower, the seed. In: Plant Anatomy. Hakkibutz Hameuhad 
Publi., Jerusalem, pp. 171–172, 321–394, 419–430.  
FAOSTAT-FAO (2010). Statistical database. Food and Agriculture Organization of theUnited 
Nations, Codex Alimentarius Commision: Tunis, Tunesia. http://www.fao.org Accessed May 
23, 2010. 
Fischer, U.A., Carle, R., Kammerer, D.R. (2011). Identification and quantification of phenolic 
compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently 
produced juices by HPLC-DAD–ESI/MS. Food Chemistry, 127(2), 807-821. 
74 
 
Freedland, S.J., Carducci, M., Kroeger, N.,  Partin, A., Rao, J.Y., Jin, Y., Kerkoutian, S., Wu, 
H., Li, Y., Creel, P., Mundy, K., Gurganus, R., Fedor, H., King, S.A., Zhang, Y., Heber, D., 
Pantuck, A.J. (2013).  
A Double-Blind, Randomized, Neoadjuvant Study of the Tissue Effects of POMx Pills in Men 
with Prostate Cancer Before Radical Prostatectomy. Cancer Prev Res, 6(10), 1120-1127. 
Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M., & Kader, A. A. (2000). 
Antioxidant activity of pomegranate juice and its relationship with phenolic composition and 
processing. Journal of Agricultural and Food Chemistry, 48(10),4581–4589. 
Goor, A. (1967). The history of the pomegranate in the Holy Land. Economic Botany, 21(3), 
215-230. 
Gözlekçi, Ş., O. Saraçoğlu, E. Onursal and M. Özgen. (2011). Total phenolic distribution of 
juice, peel, and seed extracts of four pomegranate cultivars, Pharmacognosy magazine, 7: 161-
164. 
Hajimahmoodi, M., M.R. Oveisi, N. Sadeghi, B. Jannat, M. Hajibabi, E. Farahani, M.R. 
Akrami and R. Namdar, 2008. Antioxidant properties of peel and pulp hydro-extract in ten 
Persian pomegranate cultivars, Pak J Biol Sci, 11: 1600-1604.  
Haslam, E. (2007). Vegetable tannins–Lessons of a phytochemical lifetime. Phytochemistry, 
68(22), 2713-2721. 
Hassanpour, S., M. Sadaghian, N. MaheriSis, B. Eshratkhah, M. ChaichiSemsari. 2011a. Effect 
of condensed tannin on controlling faecal protein excretion in nematode-infected sheep: in vivo 
study. J. Amer. Sci., 7(5): 896-900. 
 
Hassanpour, S., N. Maheri-Sis, B. Eshratkhah and F. Baghbani Mehmandar. 2011b. Plants and 
secondary metabolites (Tannins): A Review. Int. J. Forest, Soil and Erosion, 1 (1):47-53. ISSN 
2251- 6387. 
Ibn al-Bitar (1874). The book for the whole vocabulary of medicine and food pp. 145-47. Press, 
Damasco, (in Arabic) 
75 
 
Joseph, M.M., Aravind, S., George, S.K., Varghese, S., Sreelekha, T. (2013). A galactomannan 
polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity. 
Carbohydr. Polym., 98 (2),pp. 1466–1475 
Jahfar M,. K.K.Vijayan and Azadi P. (2003).Studies on a polysaccharide from the fruit rind of 
Punica granatum. Research Journal of Chemistry and Environment, 7(1), 43–50. 
Kulkarni, A. P., Mahal, H. S., Kapoor, S., & Aradhya, S. M. (2007). In vitro studies on the 
binding, antioxidant, and cytotoxic actions of punicalagin. Journal of Agricultural and Food 
Chemistry, 55(4), 1491–1500. 
Lansky, E. P.; Newman, R. A. (2007).Punica granatum (pomegranate) and its potential for 
prevention and treatment of inflammation and cancer. J. Ethnopharmacol, 109 (2), 177–206. 
Levin, G.M. (2006). Pomegranate roads: a Soviet botanist’s exile from Eden. pp. 15–183. 
B.L.Baer (ed.), Floreat  Press, Forestville, CA. 
Lu, Jingjing, Yun Wei, and Qipeng Yuan. (2007)."Preparative separation of punicalagin from 
pomegranate husk by high-speed countercurrent chromatography." Journal of chromatography 
B 857.(1), 175-179. 
Lu, J., Ding, K., & Yuan, Q. (2008). Determination of punicalagin isomers in pomegranate 
husk. Chromatographia, 68, 303–306. 
McCarrell, E., Gould, S., Fielder, M., Kelly, A., El Sankary, W., Naughton, D.(2008). 
Antimicrobial activities of pomegranate rind extracts: enhancement by addition of metal salts 
and vitamin C. BMC Complementary and Alternative Medicine 8, 64. 
Mena, P., Calani, L., Dall’Asta, C., Galaverna, G., García-Viguera, C., Bruni, R., Crozier, A., 
Del Rio, D. (2012). Rapid and comprehensive evaluation of (poly) phenolic compounds in 
pomegranate (Punica granatum L.) juice by UHPLC-MS
n
.  Molecules, 17(12),14821-14840 
Middha, S.K., Usha, T., Pande,V.(2013).A review on antihyperglycemic and anti-
hepatoprotective activity of ecofriendly Punica granatum peel waste. Evidence-Based 
Complementary and Alternative Medicine,Article ID 656172, 2013. 
Morton, J. 1987. Pomegranate. pp. 352–355. In: Fruits of warm climates. Miami, FL. www. 
hort.purdue.edu/newcrop/morton/pomegranate.html. 
76 
 
Noda Y, Kaneyuka T, Mori A, Packer L. (2002). Antioxidant activities of pomegranate fruit 
extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J Agric Food Chem 
50:166–71. 
Ozguven, A.I., and C. Yilmaz. (2000). Pomegranate growing in Turkey. Options Mediterrane  
´ennes Se´rie A, Se´minaires Me´diterrane´ens 42:41–48. 
Ozguven, A.I., C. Yilmaz, Y. Rehber, and M. Yilmaz.(2006). The adaptation of different 
pomegranate varieties in the north Cyprus ecological conditions. p. 37. In: ISHS, 1st Int. 
Symp., Pomegranate and Minor Mediterranean Fruits, Abstracts contributed papers, 16–19 
Oct., Adana, Turkey. 
Reddy, M., Gupta, S., Jacob, M., Khan, S., Ferreira, D.(2007). Antioxidant, antimalarial and 
antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica 
granatum L. Planta Medica 73, 461 –467. 
Romani, A., Campo, M., & Pinelli, P. (2012). HPLC/DAD/ESI-MS analyses and anti-radical 
activity of hydrolyzable tannins from different vegetal species. Food Chemistry, 130(1), 214-
221. 
Rymon D (Mapping features of the global pomegranate market. Acta Hort, 2011; 890:599–602 
Saad, H., Charrier-El Bouhtoury, F., Pizzi, A., Rode, K., Charrier, B., & Ayed, N. (2012). 
Characterization of pomegranate peels tannin extractives. Industrial Crops and Products, 40, 
239-246.  
Seeram, N. P, Lee, R., & Heber, D. (2004). Bioavailability of ellagic acid in human plasma 
after consumption of ellagitannins from pomegranate (Punica granatum L.)juice.Clinica 
Chimica Acta, 348(1), 63-68.  
Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D. (2005).In vitro 
antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total 
pomegranate tannin extract are enhanced in combination with other polyphenols as found in 
pomegranate juice. J Nutr Biochem, 16(6),360-367. 
Seeram, N., et al. "Rapid large scale purification of ellagitannins from pomegranate husk, a by-
product of the commercial juice industry." Separation and purification technology 41.1 (2005): 
49-55. 
77 
 
Sentandreu, E.; Cerd n-Calero, M.; Sendra, J. M. (2013).  Phenolic profile characterization of 
pomegranate (Punica granatum) juice by high-performance liquid chromatography with diode 
array detection coupled to an electrospray ion trap analyzer. J. Food Compos. Anal, 30(1), 32-
40. 
Van Elswijk DA, Schobel UP, Lansky EP, Irth H, van der Greef J. (2004).Rapid dereplication 
of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical 
detection coupled to mass spectrometry. Phytochem 65(2):233–41. 
Vidal, A., Fallarero, A., Pena, B.R., Medina, M.E.,Gra, B., Rivera, F., Gutierrez, Y. and 
Vuorela, P.M. (2003). Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit 
extracts. Journal of Ethnopharmacology .89: 295-300.  
Vázquez‐Araújo, L., Koppel, K., Chambers IV, E., Adhikari, K., & Carbonell‐Barrachina, A. 
A. (2011). Instrumental and sensory aroma profile of pomegranate juices from the USA: 
differences between fresh and commercial juice. Flavour and fragrance journal, 26(2), 129-
138. 
Wang, Zhenbin, et al. (2011), "Extract of phenolics from pomegranate peels." The Open Food 
Science Journal (5 ),17-25. 
Wissam, Z., et al. (2012). "Effective extraction of polyphenols and proanthocyanidins from 
pomegranate’s peel." International Journal of Pharmacy and Pharmaceutical Sciences 
4.(Supplement 3), 675-682. 
Zhou, B., Wu, Z., Li, X., Zhang, J., & Hu, X. (2008). Analysis of ellagic acid in pomegranate 
rinds by capillary electrophoresis and high performance liquid chromatography. Phytochemical 
Analysis, 19, 86–8 
Zhu, Caiping, and Xiaolin Liu.(2013)."Optimization of extraction process of crude 
polysaccharides from Pomegranate peel by response surface methodology." Carbohydrate 
polymers 92,(2) 1197-1202.  
78 
 
Recovery of polysaccharides from exocarp and mesocarp of pomegranate: the case of 
Wonderful and Laffan cultivars 
 
Mohamad Khatib, Marzia Innocenti, Camilla Giuliani, Diana Di Gioia, Giuseppe Mazzola *Nadia 
Mulinacci 
 
 
 
NEUROFARBA, Department, Pharmaceutical and Nutraceutical Division, University of Florence, 
Via Ugo Schiff 6, Sesto Fiorentino, Italy 
* Dipartimento di Scienze Agrarie, Viale Fanin, 44 40127 - Bologna 
 
 
 
* correspondence to whom should be addressed: 
nadia.mulinacci@unifi.it 
  
79 
 
Abstract  
Pomegranate (Punica granatum L.) has been used extensively in the folk medicine of many 
cultures. This fruit is well known for its ellagitannin content but it contain also polysaccharides that 
are not in deep investigated to date. It has been reported antioxidant, and antiglycation activities for 
a polysaccharide of pomegranate peel and anticancer activity in mice for a galactomannan 
recovered from the fruit rind. To date scant data have been published on the optimization of the 
extracting parameters of polysaccharides from mesocarp and exocarp, the main by-products of the 
juice production. Furthermore, no data are available on the prebiotic properties of these polymers 
recovered from pomegranate. Objectives of this study were to determine the amount of crude 
polysaccharides (CPS) in mesocarp and exocarp of pomegranate of Laffan and Wonderful cvs, to 
optimize the process in terms of shorter time and higher yield of CPS, to determine the sugar 
composition and to evaluate the prebiotic properties of these CPS by in vitro test on bifidobacteria 
and lactobacillus genera.  
The maximum extractive yields in terms of crude polysaccharides (10% w/w DM) have been 
achieved with a drug/solvent ratio of 1:40 (w/v) and applying a decoction for 60 min. The two 
varieties have been shown similar amounts, with the highest concentration in the mesocarp. 
Moreover these CPS were able to absorb up to 99,1 % of water confirming a potential use  as 
gelling agents in food chemistry. 
Finally and to the best of author’s knowledge, this is the first report that allows to demonstrate that 
CPS from pomegranate mesocarp of Laffan and Wonderful can sustain growth of beneficial and 
potentially probiotic bacteria such as those used in this study and, therefore, possess prebiotic 
properties. 
 
 
Keywords: Extraction; Sugar Composition; Gelling Capacity; Prebiotic 
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Introduction 
Natural polysaccharides from plants are biocompatible and water soluble compounds with 
antioxidant, anti-bacterial and anti-virus activities making them suitable for pharmaceutical and 
biomedical uses. Even if the ellagitannins of pomegranate (Punica granatum L.) have been 
extensively studied and the fruit is well known in folk medicine of several countries, to date only 
few reports are available on the polysaccharides of this fruit.  
Polysaccharides are a class of biological macromolecules that are relatively common in nature with 
tremendous structural diversity, and thus their biological properties have attracted substantial 
attention in medicine (Ooi & Liu, 2000; Sinha and Kumaria, 2001). Natural polysaccharides have 
been used extensively in the design of drug delivery systems due to their excellent biocompatibility, 
aqueous solubility, and stability (Bhardwaj et al., 2000; Liu et al., 2008). Some botanical 
polysaccharides have been commercially developed into important components of therapeutic drugs 
and skin care products (Deters et al., 2001; Wang and Fang, 2002) and water soluble and 
biodegradable polysaccharides have been extensively used as thickeners, gelling agents, carriers of 
hydrophobic drugs and base product to prepare nanoparticle (Marathe et al., 2002; Rubinstein, 
2000). Polysaccharides have proven to be useful candidates in the search for effective, non-toxic 
substances with pharmacological effects and represent a relatively untapped source of new drugs, 
which may provide exciting new therapeutic opportunities (Beat and Magnani, 2009). Antioxidant, 
antitumor, immunomodulatory, antimicrobial, anti ulcer, hypoglycemic activity, and several other 
pharmacological activities from have been attributed to various natural polysaccharides (Franz, 
1989; Liu, et al., 1997; Kardošová and Machová, 2006; Schepetkin and Quinn, 2006). Among the 
pharmacological properties of polysaccharides, have been cited the immunomodulatory and 
antitumor effects (Ooi and Liu, 2000). Numerous polysaccharides with in vitro antitumor effects 
have been isolated from plants, mushrooms, yeasts, algae, and lichens; of which the majority have 
been found to be non-toxic to normal cells and able to enhance the immune system of the host 
(Mahady, 2001, Leung, et al.  2006) or to act as biological response modifiers. 
Pomegranate (Punica granatum L., family of Punicaceae) has been used extensively in the folk 
medicine of many cultures (Li et al., 2006) phytochemistry and pharmacological actions suggest a 
wide range of potential clinical applications as, antitumor, antibacterial, antidiarrhoeal, antifungal, 
antiulcer, and antioxidant properties (Valadares et al., 2010). Most of these authors have been 
pointed out the main role played by the ellagitannin as principal bioactive constituents of the 
different extracts obtained from the fruit of pomegranate.  
Even if many reports have been focused on the extraction, chemical structure and biological 
activities of the antioxidants extracted from the pomegranate peels (often with this term the authors 
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mean the sum of exocarp and mesocarp) , which is reported to constitute about 45-50% of total 
weight of the fruit (Negi et al., 2003; Pan, et al.,  2012; Saad et al., 2012; Al-Said et al., 2009; 
Levin, 2006), little attention has been devoted toward the extraction of the polysaccharides from 
this part of the fruit.  
A polysaccharide from pomegranate peel have been emphasized marked antioxidant, antiglycation 
and tyrosinase inhibition properties (Rout and Banerjee 2007). A more recent study on the 
galactomannan, a polysaccharide recovered from the fruit rind  of P. granatum has shown that this 
molecules exerts in vitro cytotoxicity, immunomodulatory, and free radical scavenging (Joseph et 
al., 2012). It  shown, in vivo, anticancer activity in mice (Sreelekha et al., 2008) and also enhanced 
the survival and tumor reduction in mice bearing transplantable a scites tumors either alone and in 
combination with doxorubicin. Thus, this study provides evidence of the non-toxic nature of this 
plant-derived compounds, which could be used as an adjuvant or as single agent for the treatment of 
cancer (Joseph et al., 2013). Other authors (Li et al., 2014) reported that polysaccharides from 
pomegranate peels inhibits the proliferation of U-2 human osteosarcoma cancer cells by inducing 
apoptosis mainly through the mitochondrial signaling pathway (113).  
Recent studies have suggested that polysaccharides introduced via the diet can have prebiotic 
activity, i.e. they can stimulate the growth of beneficial bacteria in the colon thereby contributing to 
the health status of the (Marotti et al. 2011; Di Gioia et al. 2014b). The intestinal tract harbors a 
complex bacterial community, referred to as gut microbiota, which has a great impact on the 
nutritional and health status of the host (Laparra and Sanz, 2010). A balanced gut microbial 
composition confers benefits to the host, due the modulation of host metabolic and immune 
functions, while microbial imbalances are associated with metabolic disorders and/or disease status 
(Tremaroli and Backhed, 2012; Di Gioia et al. 2014a). Therefore, the maintenance of a correct 
equilibrium between beneficial microorganisms, mainly belonging to the Bifidobacterium and 
Lactobacillus genera, and potentially pathogenic strains, is crucial for host health. The presence of 
abundant bifidobacteria and lactobacilli may provide some protection against incoming of enteric 
pathogens (Jankowska et al. 2008, Symonds et al. 2012). They are able to compete for nutrient with 
enteric pathogens, to strongly adhere to the intestinal mucosa thus preventing pathogen adhesion 
and to stimulate the development of the mucosal immune system.  
To date scant data has been published on the optimization of the extracting parameters of 
polysaccharides from mesocarp and exocarp, the main by-products of the juice production. 
Furthermore, no data are available on the prebiotic properties of these polymers recovered from 
pomegranate. Objectives of this study were to determine the amount of crude polysaccharides 
(CPS) in mesocarp and exocarp of pomegranate of Laffan and Wonderful cvs, to optimize the 
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process in terms of shorter time and higher yield of CPS, to determine the sugar composition and to 
evaluate the prebiotic properties of these CPS by in vitro test on bifidobacteria and lactobacillus 
genera. 
 
Experimental Part 
Plant materials  
Fresh ripe fruits  (about 5 kg of Laffan and 20 Kg of Wonderful) from two pomegranate cultivars 
were analysed. The Laffan cv  (sour-sweet) was harvested from  Rif Idlib-Syria in October 2011; 
the Wonderful cv was purchased from Ortofrutta  Grosseto (Italy) in October 2013. The Syrian 
fruits were identified by General Commission for Scientific Agricultural Research, Damascus,  
Syria . 
Sample preparations and extraction processes  
The arils, the exocarp and the mesocarp were manually separated from fresh pomegranates, then 
washed with water separately. The fresh exocarp and mesocarp were freeze dried after cut into 
small. Both parts were powdered in a grinder immediately before the extraction applying the 
methods described below.  
Hot water extraction. The dried powdered material was boiled in distilled water under stirring for 
30, 60 or 120 min as reported in Table 1 (methods 1, 2) applying one or two successive extractive 
steps. After each boiling step, the sample was cooled and centrifuged at 4500 rpm for 8 min at 4 °C,  
to collect the supernatant  containing the CPS. The Method 3 differs from Method 2 only for a pre-
treatment of the sample: a stirring at 25 °C for 12 hrs. All the supernatants obtained applying the 
methods summarized in Table 1 were added with 2 volumes of ethanol and kept 3 h at 0 °C, to 
induce the precipitation of the CPS. Then the solutions were centrifuged at 4500 rpm for 12 min to 
recover the CPS. 
 Water extraction at room temperature. The dried powdered material was  soaked in distilled water 
1g DM/40 mL, under stirring from 8 to 24 hours, at room temperature, then to recover the CPS was 
applied the same procedure as described for methods 1-3 (Method 4). The solid residue was added 
water (ratio 1g DM/25 mL) and a single decoction of 60 min was applied. The recovery of CPS was 
done as previously described for the other methods. This procedure is named method 4 modified in 
Table 2. 
Ethanol-pretreatment and decoction. The Method 5 consists of the addition of ethanol  70 % v/v, 
with a ratio of  1g DM/40 mL,  then stirring at room temperature for 24h and a filtration to remove 
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the ethanol solution through Whatman filter paper. To the solid residue was added water (ratio 1g 
DM/25 mL) and a single decoction of 60 min was applied. The recovery of CPS was done as 
previously described for the other methods. 
 
Cleaning procedure of CPS.  
Tannin removal. All the crude polysaccharides CPS obtained applying the different methods were 
then washed with distilled water, and re-precipitated with 2 volumes of ethanol, then kept 3 h at 0 
◦C. The solutions were centrifuged at 4500 rpm for 12 min, the CPS were recovered as precipitate, 
then frozen and freeze-dried. The obtained recovery has been expressed as CPS yield (%) = 
(PS/DM) × 100; PS is the dried weight of polysaccharide in g and DM is the dried material weight 
(peel or mesocarp) in g. Protein removal. The proteins were removed with the Sevag method 
(Staub,1965) with slight modification : the CPS were dissolved in water then added with chloroform 
and a liquid/liquid extraction by  funnel was done to recover the aqueous phase containing the 
purified polysaccharide (PPS). The  extractive steps  were  repeated  several  times until the water 
chloroform inter-phase became clear (Joseph et al., 2012).  
 
Filtration of PSP solution by cut-off filter.  
Some freeze dried PPS samples were redissolved in water then  500 µl of this solution was applied 
in the  Amicon ultra filter device (cut off 10.000 Dalton) centrifuged  at 14,000 x g for about 15 
min; the precipitate was reconstituted with the original volume by adding distilled water and 
repeated the process up to 7 times to remove the  99.2% of fouling (low molecular weight materials 
and salts) from the sample as indicated by the Amicon supplier.  After these cleaning steps  the 
Amicon Ultra filter device with the unfiltered sample (PPS), was placed upside down in a clean 
micro centrifuge tube, for 2 minutes at 1.000 x g; then  500 uL of distilled water were added to 
redissolve the purified polysaccharide (PPS).  
 
Determination of the monosaccharide composition of PPS 
The PPS samples derived by purification steps of Laffan and Wonderful mesocarp and exocarp 
were hydrolyzed with a 2 M solution of trifluoroacetic acid at 120°C for 120 min, cooled on ice, 
then ultra filtered at 3500 x g for 20’ using centrifuge filter devices (Amicon ultra) having a cut off 
3.000 Dalton and the supernatant was dried in a rotary evaporator. The samples were washed twice 
with MilliQ-grade water, re-dissolved in 1 ml deionized water and then analyzed by ion exchange 
chromatography using a Dionex ICS-2500 ion chromatograph (Sunnyvale, CA) with an ED50 
pulsed amperometric detector using a gold working electrode (Dionex,Sunnyvale, CA). A Carbopac 
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PA1 4 mm by 250 mm column (Dionex, Sunnyvale,CA) was used. The eluents used were MilliQ-
grade water (solution A), 0.185 M sodium hydroxide solution (solution B), and 0.488 M sodium 
acetate solution (solution C). A gradient elution was used consisting of a first stage (injection time 
to the 7th min) with an eluant constituted by 84% solution A, 15% solution B, and 1% solution C; a 
second stage (injection time from the 7th to 13th min) with 50% solution B and 50% solution C; 
and a final stage (injection time from the 13th to the 30th min) with 84% solution A, 15% solution 
B, and 1% solution C. The flow rate was 1 ml min
-1
. Unknown monosaccharides were detected 
according to retention time of standards purchased from Sigma. 
 
In vitro evaluation of the prebiotic properties  
The capability of CPS of stimulating the growth of beneficial bacteria (prebiotic activity) was 
assayed using as target strains Bifidobacterium breve B632, previously isolated from infant feces 
(Aloisio et al. 2012) and L. plantarum L12, previously isolated from adult feces (unpublished 
results) and available at the Bologna University Scardovi Collection of Bifidobacteria. The strains 
were stored as liophylized strains. When necessary, they were re-vitalized in de Man Rogosa Sharpe 
(MRS) medium (Oxoid, Basingstone, UK) additioned with 0.05% cysteine and grown in anaerobic 
conditions at 37 °C for 24 h. Anaerobic conditions were created in a capped jar using an anaerobic 
atmosphere generation system (Anaerocult A, Merck, Darmstadt, Germany).  
The MRS medium composition was modified to perform the growth experiment with the 
pomegranate polisaccharides. The modified medium (m-MRS) did not contain the carbon source 
(glucose), which was provided by the pomegranate polysaccharide, and had a halved amount of 
potential growth substrate, such as peptone, yeast extract and meat extract with respect to those 
present in the original medium (peptone, 5 g/L; yeast extract, 2 g/L, meat extract 5 g/L were the 
amount in m-MRS).  
The prebiotic activity was evaluated using CPS at 0.5 % (w/v) in m-MRS. A positive growth 
control was performed using m-MRS with 0.05 % glucose and a negative control in m-MRS with 
no added carbon source. The medium containing CPS as the carbon source was prepared as follows: 
the m-MRS ingredients were weighted in a flask, dissolved in water and the medium was 
autoclaved at 120 °C for 15 min. 0.5% (w/v) fiber or glucose at the same concentration were added 
to the hot medium, stirred, and sterilized again at 102 °C for 10 min. This procedure allowed the 
fiber to dissolve in the medium and prevented risk of growth of undesired microorganisms. The B. 
breve B632  and L. plantarum M12 strains were grown overnight in the respective media, 
centrifuged, washed in phosphate buffered saline (PBS) and re-suspended PBS to obtain a solution 
having an Absorbance at 600 nm of 0.7. This suspension was used to inoculate at 2% (v/v) the flaks 
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containing the m-MRS medium plus the fiber, the m-MRS medium plus glucose (positive control) 
and the m-MRS medium with no additional carbon source (negative control). The flasks were 
incubated at 37 °C in anaerobic conditions for 48 hours and 1 mL culture was sampled from each 
flask for viable bacterial counts at pre-established times (0, 6, 24, 30 and 48 hours of incubation). 
The sampled amount was mixed with 9 mL of PBS, serially diluted in the same solution and plated 
on agarized MRS additioned with cysteine. Following incubation of the plates at 37 °C in anaerobic 
conditions for 24 h, the number of colonies, corresponding to the number of viable cells, was 
counted. The number of cells expressed as CFU/mL were transformed to Log10 value (Log 
CFU/mL). 
 
Results and Discussion 
In recent decades, plant polysaccharides have attracted a great deal of attention in the biomedical 
field due to their broad spectra of therapeutic properties and relatively low toxicity. Nevertheless 
little attention has been devoted to the polysaccharides of pomegranate fruit. The most commonly 
method applied to recover these polymers is the use of hot water, followed by precipitation of 
interfering substances such as proteins, then collection of supernatant after centrifugation and a 
precipitation of polysaccharides by adding of ethanol (Huie and Di, 2004). In this study a similar 
procedure was applied to mesocarp and exocarp separately to evaluate their polysaccharide content. 
 
CPS from Mesocarp 
Three independent major variables, including extraction time (h), extraction temperature (◦C) and 
ratio of raw material/ water (g/ml), were considered of significance for the extractive yields and 
were modified during this study. The first step was to test different methods working on mesocarp 
of Laffan pomegranate; in Table 1 were summarized the applied procedures.  
The extraction time was firstly set at 30’ and then at 60’, in a single or two successive steps; the 
elective solvent was water for Methods 1-4, while also an hydro alcoholic solution was evaluated 
with Method 5, followed by a successive decoction. The extraction temperature was 100 °C for the 
hot treatments with water and room temperature only for Method 4. Finally the ratio raw 
material/extractive solvent was firstly 1:15 (Method 1) and then 1:40 for all the other methods. The 
choice of the best experimental parameters was done on the base of the percentage yields of the 
weight of crude polysaccharides (CPS) with respect to the weight of dried mesocarp (Table 1).  
Applying a drug/solvent ratio of 1:15 (w/v), the yield of CPS increased from 5% to 8% when the 
extraction time was prolonged from 30’ to 60’, in two successive steps. This results are in 
agreement with previous data that pointed out the relevance of the extraction time to recover these 
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polymers from pomegranate (Zhongdong et al., 2006). Other authors underlined as the exposure of 
CPS to the extractive medium is a relevant aspect to favor the penetration of the liquid into the dried 
powdered material, dissolve the polysaccharide and allow the successive diffusion out of the matrix 
into the extraction solvent (Ye & Jiang, 2011). 
 
 
Table 1:  Different extractive methods applied to recover the crude polysaccharides from the Laffan 
mesocarp and corresponding extractive yields on DM. §The tests were carried out in triplicate from 
dried mesocarp; *sample under stirring.  
 
 
 
 
 
 
 
 
Method 
Dried weight 
(g)/ solvent 
(mL) 
Solvent T (°C) 
Time 
(min) 
Steps 
Yield (%) 
CPS/DW 
mesocarp 
Method 1 
 
1/15 
H2O 100 30 1 5 
H2O 100 30+30 2 8 
Method 2 1/40 H2O 100 60 1 10 
§Method 2 1/40 H2O 100 60+ 60 2 9.8 
§Method 3 1/40 H2O ~25 60+ 60 2 9,1 
§*Method 4 1/40 H2O ~25 8-24 h 1 2-3.33 
§*Method 4 
modified 
1/25 H2O 100 60 1 7,8 
§*Method 5 1/25 H2O 100 60 1 7,15 
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According to Table 1 the CPS yields achieved a maximum value, close to 10% with a drug/solvent 
ratio of  1:40 (w/v) and applying an extraction time of 60’ (Method 2) in a single step. Applying a 
second step of 60’ and maintaining the same drug/solvent ratio, it was not observed a consistent 
increase of the yields, with only a recovered of very small amounts (0,36 – 0,5 %). In light on these 
results it was chosen one hour as extraction time because considered an enough time for recovering 
most of the CPS from mesocarp. Furthermore, it has been also observed that the stirring of the 
sample before the boiling process does not lead to an increase of the yields extractive . 
After this pre-screening working only on the Laffan mesocarp some of these procedures have been 
also applied to the other matrices and in Table 2 is shown a comparison in terms of % extractive 
yields of CPS from mesocarp of Laffan and Wonderful. Again the recovery obtained working at 
room temperature (Method 4) was considerably lower and close to 2% DM after 8 hours of stirring, 
and up to 3,33 % after 24 hrs of stirring (Table 2). A successive boiling of the solid residue (Method 
4 modified), allowed to increase the yield up to 7,80%±0,28 for Laffan cv and 5,67 % ±0,58 for 
Wonderful cv. These results support the use of an hot treatment for recovering CPS, due to the 
higher solubility of these polymers in hot water and agree with previous reported findings (Sun Li, 
et al., 2010; Sun Liu, et al., 2010; Yin and Dang, 2008).  
Overall, for both the exocarp and mesocarp of Laffan and Wonderful the best procedure in terms of 
% CPS/DM was the method 2 with the following experimental conditions: dried material/water 
ratio of 1g /40 mL, extraction temperature 100 °C and 60 min in a single step as extraction time. 
Under these conditions the maximum yields were for mesocarp with values ranging from 8 ±0,01 % 
for Wonderful and 9,80±0,28 for Laffan (Table 2). The obtained yields are in agreement with 
previous data from peel of pomegranate (Zhu and  Liu ,2013).  
Finally, with the objective to avoid a co-precipitation of the ellagitannins together with the CPS, a 
different procedure (Method 5) was applied. This procedure was characterized by a first extraction 
of the ellagitannins from the mesocarp by an hydroalcoholic mixture at room temperature (see 
chapter 4 of this Thesis), then the solid residue was treated with hot water (decoction) to recover the 
CPS. It was observed that the boiling of the dried mesocarp without a pretreatment, involved a 
partially co-precipitation of ellagitannins, thus making necessary to wash the CPS to remove this 
fraction (Figure 2). Nevertheless with method 5 the yields of CPS were below (6,70±0,66 % for 
Wonderful and 7,15±0,21 for Laffan) if compared with those derived by method 2 (Table 2). 
Anyway this approach can be useful if the objective is to obtain a polysaccharide fraction free of 
tannins.  
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CPS from exocarp 
Regarding the exocarp, a similar trend for the two cvs, was observed, although the polysaccharide 
content is lower than that of mesocarp; the maximum values are between 4,47±0,50 % for Laffan cv 
4,7±1,15 % for Wonderful obtained again with method 2 (Table 2). As expected, the percentages of 
CPS from the exocarp show a higher variability (RSD from 11% to 25 %) mainly related to the non 
homogeneous thickness of the raw material that contain a variable residual part of mesocarp 
difficult to be removed. On the opposite, a very good reproducibility of the extractive method (RSD 
below 3%) was obtained for the mesocarp.  
The decoction after extraction with EtOH: H2O
+
 (7:3 v/v) allowed to obtain CPS amounts near 4 % 
for the two cvs and similar to those derived by method 2. On the opposite, for both the cvs a lower 
recovery (close to 1,93 % CPS) is derived by the extraction at room temperature; this latter result is 
also in agreement with literature data (Rout and Banerjee, 2007). 
 
 
Table 2: Polysaccharides content (CPS) in mesocarp and exocarp  of Wonderful and Laffan. The values are 
a mean of triplicates.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Procedures Samples 
Yield (%) 
CPS/DW mesocarp 
Yield (%) 
CPS/DW exocarp 
Method 2 
Laffan 9,80±0,28 4,47±0,50 
Wonderful 8±0,00 4,7±1,15 
Method 4 
Laffan 3,7±0,42 1,93±0,23 
Wonderful 3,33±1,15 1,99±0,02 
Method 4 
modified 
Laffan 7,80±0,28 4,20±0,20 
Wonderful 5,67±0,58 4,13±0,31 
Method 5 
Laffan 7,15±0,21 3,93±0,12 
Wonderful 6,70±0,66 4,07±0,31 
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Washing of crude polysaccharide  
For impurities determination in mesocarp and exocarp, the crude polysaccharides were dissolved in 
distilled water and re-precipitated again with ethanol to evaluate the amount of these impurities by a 
gravimetric determination. Amounts of non-polysaccharide substances (impurities such as proteins, 
ellagitannins and other polar compounds) varies depending on the extraction method; applying an 
hot water extraction (Method 2) to the mesocarp the amounts of these impurities evaluated as dried 
weight range from 74 mg/g DM for Laffan, to 50 mg/g DM for Wonderful. Regarding the exocarp 
these residues are close to 30 mg/g DM for both these cultivars. From this control it emerges that 
only low amounts of impurities are entrapped in the CPS and  the values range from 2-6 mg/g for 
both mesocarp and exocarp of the two cvs. In light of these data it can be concluded that the 
washing process of CPS is not necessary particularly when applying the extractive methods 4 and 5. 
The co-precipitation of ellagitannins together with the other impurities within the CPS leads 
contributes to confer a dark color of this crude fraction. In light of this observation the ellagitannins 
entrapped in the CPS have been evaluated by HPLC/DAD applying a method previously optimized 
(see chapter 4 of this Thesis).  
 
Figure 2. Amounts of the ellagitannins co-precipitated in the CPS from Laffan and Wonderful 
mesocarp and exocarp. The data are a mean of triplicates. 
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Regarding the mesocarp the values ranged from 11,52 ± 1,09 mg/g DM for Laffan cv to 6,47 ± 0,82 
mg /g DM for Wonderful cv, while the exocarp showed lower amounts ranging from 3,93 ± 0,49 
mg /g DM for Laffan cv, to 3,87± 0,39 mg/g DM for Wonderful cv after washing the 
polysaccharides obtained by Method 2.  
 
Sugar composition by hydrolysis  
Samples were treated with trifluoroacetic acid to hydrolyze the polysaccharide strands and 
subsequently determine sugar composition by ion exchange chromatography according to previous 
methods (Erbing et al,. 1995). The composition of four purified polysaccharide fractions is reported 
in Table 3. On the whole, diverse monosaccharides were found, and these samples showed a very 
similar composition for both the cultivars. Within the hexoses galactose, glucose/mannose, and 
fructose; then aldopentose arabinose, pentose xylose, rhamnose and galacturonic acid were found 
(Table 3). Glucose and mannose, having very close retention times, were co-eluted in one peak on 
the chromatograms. In the entire analyzed sample, glucose, xylose and glucuronic acid were the 
most abundant sugars (Table 3).  
Normakhmatov, Rakhnmnberdyeva, & Rakhimov (1999) pointed out that the main monosaccharides 
in the water-soluble polysaccharides from pomegranate peel varied with the growth site, and were 
constituted by glucose, galactose and xylose, with larger amounts of xylose, arabinose and galactose 
detected in the peel of other varieties of pomegranate harvested in different growth sites. In another 
study the composition of a polysaccharide from pomegranate peel showed glucose at 52.8% and 
glucuronic acids at 33.5%. Other monosaccharides included arabinose and  galactose close to 5.0%, 
mannose and rhamnose close to 1.6% and only 0.5% for xylose. (Jahfar, Vijayan, & Azadi, 2003).  
From the few reports available to date on polysaccharides of pomegranate fruits, it emerges that 
there is a certain variability in the sugar composition that is mainly related to the variety and growth 
site but is also affected by the different purity grade of the polysaccharide itself, as analyzed by 
various authors. Notably, the two cultivars (one mainly localized in Syria and the other widely 
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diffused throughout the western world) showed a very similar compositional profile of the 
polysaccharides. However, this result is not completely unexpected, and is in agreement with a 
previous document that hypothesized that the Wonderful variety is derived from the more ancient 
Laffan cultivar (Goor, 1967). Glucofructan from the pectin of the peel, having a molecular weight 
31,000, was also detected using a Sephadex G-100 column (Khodzhaeva et al., 1985). Further 
studies will be performed to define the molecular weight of these polysaccharides applying a gel 
permeation method and by the use of mass measurements with MALDI . 
Table 3: Sugar composition of the crude polysaccharides obtained by chemical hydrolysis (Erbing et al,. 
1995).The name of the samples have been defined as follow: Ps for polysaccharides;  M  for mesocarp and E 
for exocarp; L1 for Laffan  and  W1  for Wonderful. 
 
 
 
 
 
 
 
 
 
A filtration step by the use of filter with 10.000 Dalton as cut off was applied to further purify the 
polysaccharide from mesocarp of Table 3 and then submitted to the chemical hydrolysis. It emerges 
that the two samples before and after cut off-filtration gave the same results in terms of molar % for 
all the sugars (data not shown) implying a lack of interference compounds (e.g., salts). These results 
suggest that the samples in Table 3 do not need to be further purified by the use of these filter 
device before the chemical hydrolysis. 
 
Gelling capacity of CPS. 
 Molar % 
Sugars PsMW1 PsML1 PsEW1 PsEL1 
Rhamnose 13,25 11,33 3,20 3,18 
Arabinose 27,36 28,02 35,63 26,67 
Galactose 6,22 8,76 11,06 10,68 
Glucose 34,98 29,09 39,24 25,33 
Xylose 8,63 6,93 5,26 1,47 
Fructose 0,39 0,35 0,42 0 
Galacturonic acid. 33,18 43,91 28,76 32,94 
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The water holding capacity of plant polysaccharides is determined by their chemical and structural 
properties and also by the pH and osmolality of the surrounding fluids (Eastwood  et al.,1976) 
.When expressed as water retained per gram of dried material, a range of 1,5 g water per gram of 
fiber for maize to 23,7 g water per gram of fiber for lettuce has been reported (Eastwood et 
al.,1976; Connell et al.,1974 ). It is well known as purified plant fibers such as carrageenan can 
form gels containing 99% of water/g dried material (Eastwood  et al.,1973).  
A preliminary test was carried out on some CPS extracted in this work to evaluate their gelling 
capacity by measuring the amount of adsorbed-entrapped water. The % of water adsorbed by CPS 
of pomegranate ranged from 98,6 to 99,1 % confirming these polymers as potential gelling agents 
to be used in food chemistry (Table 4). These preliminary data, helping to improve the knowledge 
on the physical properties of the polysaccharides recovered by a typical by-products of pomegranate 
fruit, add value to this waste and open future perspective for its optimal use. 
 
Table 4. Gelling capacity evaluated by the % of the adsorbed water .CPS: crude polysaccharides  
E= exocarp; M= Mesocarp; W = Wonderful; L= Laffan 
 
 
 
 
 
 
 
In vitro evaluation of prebiotic properties.  
In this study the ability of B. breve B632 and L. plantarum L12 strains to use crude polysaccharides 
from pomegranate exocarp and mesocarp as the carbon source was studied and compared to growth 
on glucose, i.e. an easily fermented carbon source.  
Figure 2 shows that both strains could grow well on the CPS of Laffan and Wonderful mesocarp 
reaching the maximum growth on these substrate after 24 hours of incubation. Growth at 24 h on 
the Laffan variety was 0.6 and 0.1 Log CFU/mL lower with respect to that on glucose for L. 
plantarum L12 and B. breve B632, respectively. Growth at 24 h on the Wonderful variety was 1.0 
and 0.2 Log CFU/ml lower with respect to that on glucose for the same strains. Growth on glucose 
was also maximum at 24 h of incubation but, differently from the Laffan CPS, the stationary phase 
Samples 
Amount of CPS  
(g) 
% H2O 
CPSML 0,32 99,2 
CPSMW 0,3 99 
CPSEW 0,3 98,6 
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was longer, lasting at least until 30
th
 hour. A longer stationary phase was also observed for the 
Wonderful variety in the B. breve strain. Growth on the medium with no added carbon source was 1 
Log CFU7mL at 24 hours compared to the beginning of incubation.  
On the whole, the results obtained allow to conclude that CPS from pomegranate mesocarp of 
Laffan and Wonderful can sustain growth of beneficial and potentially probiotic bacteria such as 
those used in this study and, therefore, possess prebiotic properties. Growth of the Lactobacillus 
strain on the Laffan variety was higher with respect to the Wonderful one, whereas growth of the 
Bifidobacterium strain was very similar on the CPS deriving from both varieties.  
 
Figure 2. Evaluation of prebiotic properties of CPS from mesocarp of Laffan and Wonderful on the 
L. planctarum PCS20 (a) and Bifidobacterium breve B632. 
C-: growth obtained on m-MRS with no added carbon source 
C+: growth obtained on m-MRS with 0.5 % glucose 
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Abstract  
The Capparis spinosa L. has a wide distribution in the Old World from South Europe, North 
and East Africa, Madagascar, Southwest and Central Asia to Australia and Oceania. The 
relationship between capers and human beings can be traced back to the Stone Age. The 
traditional use of Capparis spinosa root as remedy against different pains in human is well 
known since the antiquity as highlighted by recent review. 
Various secondary metabolites have been found in caper plant, among them alkaloids, phenols, 
sterols, most of them in free or glycosylated forms. Nevertheless, few studies have been 
focused to the analysis of root constituents. To date, three main alkaloids (capparispine, 
capparispine 26-O-β-D-glucoside and cadabicine 26-O-β-D-glucoside) have been isolated from 
the root of C. spinosa and a more polar derivative, the stachydrine. 
Aim of this work was to improve the knowledge on the alkaloid content of the root of a Syrian 
sample of C. spinosa. To this scope decoction, hydro-alcoholic and dichloromethane extracts 
have been prepared and analyzed by HPLC-DAD-MS. To the best of our knowledge, this is the 
first HPLC-DAD-MS profile that pointed out the copresence of stackydrine, several isobaric 
forms of capparispine and/or capparisine in free and glycosylated forms and some isobars of 
isocodonocarpine or codonocarpine all extracted from a sample of C. spinosa root. The 
quantitative evaluation was carried out by the use of cynnamic acid as external standard. The 
total alkaloids were almost doubled in hydro alcoholic extract (2,8 mg/g dried root) with 
respect to decoction. Coupling the use of ultrasounds even if of low potency, with the ethanol 
mixture, an increment close to 30% of the extractive yield was  reached (3,9 mg/g dried root).   
Finally, the use of methylene chloride for a fractionation process allowed to increase the 
alkaloids amount almost of 7 times with respect to the native hydro alcoholic sample. 
 
 
 
 
Keywords: capparisine; glycosilated alkaloids; stachydrine  
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Introduction  
 
The Capparis spinosa L. has a wide distribution in the Old World from South Europe, North 
and East Africa, Madagascar, Southwest and Central Asia to Australia and Oceania (Jacobs, 
1965; Fici, 2004). The caper is a perennial spiny shrub, which can be found growing wild 
everywhere in Syria around dry and rocky areas. It is particularly abundant in the harsh 
environments of Euphrates valley, Aleppo province, Idlib, Salamie area of the Hama province, 
and in Al Jazira (northeastern Syria). The caper is adapted to dry heat and intense sunlight. 
Capparis spinosa L. is a valuable commodity for the resource poor nomadic communities 
living in the Syrian desert. While caper is widely cultivated in other Mediterranean countries, in 
Syria the caper is a wild species and cultivations are only found in the research nurseries. 
Unlike to other countries, the caper buds collected before flowering are used in Syria as trade 
items (Giuliani and Padulosi, 2005). The caper buds are collected by private enterprises, then 
sell to foreign traders of the neighboring countries, mainly of Turkey. The foreign factories 
process the capers, and sell them to the European countries. The estimated yearly harvest is 
about 4000 tons that corresponds to only a quarter of the potential caper that could be harvested 
(Giuliani, 2005).  
 
The value of caper in antiquity. The relationship between capers and human beings can be 
traced back to the Stone Age. Rests of Capparis spinosa were unearthed in archaeological sites 
in Syria as early as the lower Mesolithic (on the area of Tell Abu Hureyra, 9500–9000 B.C., 
Hansen, 1991). Carbonized flower buds and unripe fruits were unearthed in a jar at the site of 
Tell es-Sweyhat, Syria, dated to about 2400–1400 B.C., and were considered to be stored as a 
condiment (Van Zeist and Bakker-Heeres, 1985). The first recorded use of the caper bush for 
medicinal purposes was by the Sumerians in 2000 BC: the root bark of caper was used as 
analgesic and carminative agent Sher and Alyemeni, (2010). A high economic and medicinal 
value in different traditional medicines like Iranian, Unani, Chinese, Ayurvedic and Greco-
Arabian contexts has been recognized for this plant. The plant is widely known with the 
common name caper in several countries (Azaizeh et al., 2003) and the different parts of the 
plant can be easily found at herbal markets in Syria (Giuliani et al. 2005). Several authors (Al-
Said et al. 1988; Sher and Alyemeni, 2010) reported that in traditional medicines teas made 
with caper root and young shoots are considered to be beneficial for the treatment of 
rheumatism and stomach problems, against colicky pains, dyspepsia, dropsy, anemia and gout 
(Inocenico et al., 2002; Eddouks et al., 2004; Lemhadri, 2007). The moist pastes prepared from 
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the root bark are used for topic applications to treat swollen joints, skin rashes, burns, wounds 
and dry skin (Eddouks et al., 2004), and also as cataplasm for spleen troubles. The oral 
administration of the root bark has been described as appetizer, purgative, emmenagogue, and 
expectorant against chest diseases (Yadav, 2013), but also as diuretic and tonic (Batanouny et 
al, 1999). According to Calabrian popular medicine (southern Italy) the decoction of roots of C. 
spinosa L. is used to cure several diseases of the mucous membranes such as abscesses of the 
oral cavity (Boga et al. 2011).  
Dr. A. Kattaa, from Aleppo University, has pointed out the medicinal value of caper plant in 
Syria reporting its use as good coadjutant for the immune system; the Syrian people use to 
drink the water where the roots have been previously soaked (Giuliani et al. 2005). The 
powdered root, mixed with olive and other oils, is used to treat rheumatism and diseases of the 
urinary tract (Giuliani, 2005).   
The traditional use of Capparis spinosa root as remedy against different pains in human is well 
known since the antiquity as highlighted by a recent review (Jiang et al, 2007). The powdered 
root is widely use for oral administration in the Syrian tradition, alone or associated to local 
applications on the painful part of “dough” prepared mixing the powder with water. In 
Jordanian traditional medicine, the root bark are macerated and placed between gauze on 
aching area for 15-25 min in order to relieve the inflammation and muscle pain (Hudaib et al., 
2008). This ability to reduce pain in humans is particularly interesting because few natural 
compounds have been recognized as efficacious to date.  
 
Root composition. Various secondary metabolites have been found in caper plant, among them 
alkaloids, phenols, sterols, most of them in free or glycosylated forms. Nevertheless, few 
studies have been focused to the analysis of root constituents. Three main alkaloids, 
capparispine, capparispine 26-O-β-D-glucoside and cadabicine 26-O-β-D-glucoside, have been 
isolated from the root of C. spinosa (Fu et al., 2008). The spermidine alkaloids, 
isocodonocarpine, capparidisine and capparisinine, have been isolated from the dried root barks 
of C. deciduas, and their structures were elucidated by mass spectrometry, UV, IR and NMR 
spectroscopy (Ahmad et al., 1985; Ahmad et al., 1987; Ahmad et al., 1989). Successively, two 
new N-acetylated spermidine alkaloids, 14-N-acetylisocodonocarpine and 15-N-
acetylcapparisine, have been isolated from the roots by the same research group (Ahmad et al., 
1992). Other recently isolated compounds from C. deciduas root are capparisine, 
codonocarpine, cadabacine, rutin, l-stachydrine and β-sitosterol (Rathee et al., 2010; Mishra et 
al., 2007). For the first time in 1969, the alkaloid stachydrine was isolated from the root of 
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Capparis spinosa (Multhamedova et al., 1969; Afsharypuor and Jazy, 1999). Both the root bark 
and the leaves contain stachydrine and 3-hydroxystachydrine, while glucobrassicin, 
neoglucobrassicin and 4-methoxy-glucobrassicin have been found only in the root (Batanouny 
and Lamnauer, 2005 ). 
   
  
 
Pharmacological activities of the alkaloids of C. spinosa roots. The presence of spermidine 
alkaloids like capparidisine, capparisine or capparisinine in root bark of C. aphylla (Syn. 
Capparis decidua Edgew) reminds for careful use of Capparis plant in dietary or medicinal 
supplements (Rastogi RP & Mehrotra, 1995). Isocodonocarpine, present in roots was found to 
be responsible for antinflammatory and anti-asthmatic activity (Ahmad et al., 1992). The l-
stachydrine exhibited anti-tuberculosis property i n  in vivo experiments (Tandon et al., 1961; 
Gaind and Juneja, 1970). This compound was able to increase the blood coagulation, thus 
shortening bleeding time and blood loss (Asolkar et al., 1992). The assumption of generous 
quantities of alkaloids, e.g., spermidine alkaloids and stachydrine, induced a depressant activity 
on central nervous system in rats (Aniszewski, 2007). Since the antiquity, the stachydrine 
containing species are widely used against rheumatism and other diseases in traditional 
medicines (Buckingham, 1994). Stachydrine was recognized as a potent anti-metastatic agent, 
which markedly inhibited invasive capacity of malignant cancer cells (Lam et al., 2009).  
Overall, in more recent literature, numerous studies about the biological properties of the C. 
spinosa L. are reported. However, the majority of these reports are related to the aerial parts of 
the plant, such as flowers and fruits. Other studies concerning the leaves have been published, 
but less attention has been devoted to the roots of C. spinosa L.  
Aim of this work was to improve the knowledge on the alkaloid content of the root of a Syrian 
sample of C. spinosa. Decoction, hydro-alcoholic and dichloromethane extracts have been 
prepared and analyzed by HPLC-DAD-MS. The different extracts obtained from the whole 
powdered root and from external and internal parts have been evaluated in terms of alkaloids 
content. 
 
Experimental section 
Samples 
The roots of Capparis spinosa L. (Capparaceae) were collected from Kafr Nabl, province of 
Idlib, in the north of Syria in 2011. The sample was authenticated by General Commission for 
Scientific Agricultural Research, Damascus, Syria. The roots were freeze-dried as whole and 
maintained at room temperature, in dark until the analyses.  
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Ethanol and water extraction. The extraction has been performed on the whole root, and on the 
root cortex and internal part separately. For all the extracts the applied drug/solvent ratio was 
1:30 w/v starting always from the dried powdered material. The extraction with ethanol-water 
mixture 7:3 v/v was done in two successive steps (each of 12 h) on the powdered root stirred at 
room temperature. Exactly the same procedure was applied adding a sonication step of 30 min 
(35 MHz) for twice. The extracts were then filtered through Whatman filter paper to remove 
solid residue obtaining the sample EtH2O. The decoction was done on dried powdered material 
boiled in distilled water under stirring for 1 hour; after cooling and filtration to collect the 
supernatant. This solution was treated with 2 volumes of ethanol and kept for 3 h at 0 °C for 
precipitation of crude polysaccharides and other impurities, then the solutions were centrifuged 
at 4500 rpm for 12 min to remove the precipitate obtaining the sample DEC. All the extracts 
were dried under vacuum at 30°C, then redissolved in a mixture of EtOH/H2O (7:3 v/v) and 
centrifuged at 14,000 rpm, 5 min, before HPLC/DAD analysis.  
 
Selective extraction of alkaloids. Briefly, an aliquot exactly measured of the hydro alcoholic 
extract was dried until water residue (below 30°C), added with NH3 until pH 10, then CH2Cl2 
was used for a liquid-liquid extraction (two steps, each with the same volume of the water 
residue). Then was used ethyl acetate in the same manner of methylene chloride (see Fig. 6). 
The organic phases were dried and dissolved in acidified mixture of ethanol/water/formic acid 
70:30:1 v/v/v obtaining the CH2Cl2 and EtOAc samples for HPLC-DAD and HPLC-MS/MS 
analyses. The same procedure was applied to the water residue (H2O-Res) to prepare the 
sample for the instrumental analysis. 
 
HPLC/DAD analyses  
The analyses were carried out using a HP 1200L liquid chromatograph equipped with a DAD 
detector (Agilent Technologies, Palo Alto, CA, USA). A 150 mm × 2 mm i.d., 4 μm Fusion, 
RP 80 A, column (Phenomenex, USA) equipped with a pre-column of the same phase was 
used. The mobile phases were (A) 0.1% formic acid/water and (B) CH3CN. The multi-step 
linear solvent gradient used was: 0-2 min 2 % B; 2–20 min, 2–25% B; 20–25 min 25–35% B; 
25–28 min 35–95% B; 28–32 min 95–95% with a final plateau of 2 min at 2%B; equilibration 
time 10 min; flow rate 0.4 mL min−1 and oven temperature 26 ◦C; injection volume 5 μL. The 
UV-Vis spectra were recorded in the range 220–500 nm and the chromatograms were acquired 
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at 280, 350 nm. All solvents used were of HPLC grade; CH3CN was from E. Merck 
(Darmstadt, Germany). 
 
The MS and MS/MS experiments 
The MS and MS/MS experiments were done in positive and negative mode using the same 
column and applying the elution method previously described for the HPLC/DAD analyses. 
The UHPLC was a Platin Blue (Knauer, Berlin, Germany), operating in the same conditions as 
described for HPLC-DAD analyses. The UHPLC was directly connected to a LTQ linear 
quadrupole ion trap mass spectrometer (Thermo Scientific, Bremen, Germany) through an ESI 
interface. The analyses were performed in scan mode in the range 134-800 m/z, alternating the 
two polarities. Instrumental parameters are listed below in Table 1. 
 
 
  
  
 
 
Nitrogen was used as the sheath, sweep and auxiliary gas at the flow rate of 28, 6 and 4 
(arbitrary units), respectively. The capillary temperature was 295°C. 
The MS/MS and MS/MS/MS experiments were performed on some selected precursor ions in 
positive ion mode, at 144.1 m/z, 598.3 m/z and 436.2 m/z other ion 466. The precursor ions 
were isolated using a 3 mass unit width, collided with helium gas in the ion trap (Q 0.25, 
excitation time 30 msec) at 30% relative collision energy. The principal product ion of 598.3 
m/z was at 436.2 m/z: this ion was also isolated and collided (30% relative collision energy) for 
MS/MS/MS experiment and its product ion spectrum recorded. The principal product ion of 
436.2 m/z was also isolated and collided (27% relative collision energy) for MS/MS/MS 
experiment: the product ion spectrum of 348.1 m/z was recorded in the range m/z 95-460.  
 
Quantitative evaluation of the alkaloid content  
The quantitative evaluation of the main alkaloids was performed through the use of the p-
coumaric acid as external standard (purity grade 98% by HPLC, purchased from Sigma-
Aldrich, Germany). A five-point calibration curve was built at 280 nm, linearity range between 
0.22 μg and 2.21 μg, R² 0,998. 
  
Positive 
Ions 
Parameter Negative Ions 
4700 Spray voltage (V) - 4400 
20 Capillary voltage (V) -40 
90 Tube lens offset (V) -55 
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Results and discussion  
 
Chemical characterization 
Different extraction processes were performed on the powdered root trying to have a more 
complete picture of the secondary metabolites of the root, particularly of the alkaloids. To this 
aim, a decoction for 1 h, an extraction with ethanol at 70% v/v have been applied to the whole 
root but also on the external and internal parts, separately. The use of acetone at room 
temperature have been also applied but this solvent resulted in a poor extractive capacity 
compared with the hydro alcoholic and water extracts (data not shown), therefore not further 
used. The HPLC-DAD and HPLC-MS methods were optimized working on the hydro alcoholic 
extract from whole root as reference sample. The optimized elution procedure on the Fusion 
column was then applied to analyze all the other extracts; a profile at 280 nm of the main 
components of the reference extract is shown in Figure 1. 
 
Figure 1. HPLC/DAD profiles at 280 nm of the hydro alcoholic extract (see also Table 3, sample 2- 
EtH2O) of the whole root. 
 
 
 
The same hydroalcoholic extract was then submitted to HPLC-MS and MS/MS analyses. The 
first full scan experiment was performed to check for the presence of molecular ions of the 
alkaloids cadabicine and capparispine in free or glycosylated forms, previously found in the 
root of Capparis spinosa (Fu et al., 2008; Khanfar et al., 2003) but also in other species as 
Capparis decidua (Arif, 1986).  
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Figure 2. (a) Base peak chromatogram of the hydro alcoholic extract of dried root of C. spinosa (black) 
with the associated extracted ion profiles at 436 m/z (red) and 598 m/z (green); the last two profiles are 
related to the main alkaloids in free and monoglycosylated forms as better highlighted by the zoom of 
the two areas (b).  
a 
  
b  
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Figure 2 shows the base peak chromatogram with a group of main signals in the range 10-13 
min; and another series of peaks with a minor intensity related to more lipophylic compounds 
in the range 21-26 min.  
The ion current profile of m/z 436 (Figure 2b) completely overlaps with the base peak profile 
showing also the same intensity of 3,4 E6. This profile highlights the presence of four isobaric 
forms but with strong differences in terms of relative ion intensity. Observing the profile in 
Figure 2c, it was possible to point out the presence of another group of peaks corresponding to 
at least four isobaric monoglycosides (mw 597 Dalton), attributable to cadabicine and/or 
capparispine derivatives. The intensity of the ions at 598 m/z [M+H]
+ 
was one order of 
magnitude less intense compared to 436 m/z and taking into account that the glycosidic forms 
can be easily ionized in ESI-MS experiments, it can be assessed that the mono glycosilated 
alkaloids are in lower amount with respect to the corresponding free forms. Furthermore, the 
lower retention times of these glycosylated forms with respect to the peaks of the free alkaloids 
in the HPLC on reverse phase, are in agreement with the different polarity of these two groups 
of compounds. In Figure 3 are shown some reference structures of the main alkaloids detected 
in C. spinosa to date. 
The next step was to carry out an HPLC-MS/MS experiment in positive ionization mode 
focused to induce the fragmentation of the main alkaloids by the selection of the corresponding 
protonated molecular ion at 436 Dalton. In Figure 4 the MS/MS spectra of the four isobars are 
compared, all showing the fragment ion at 419 m/z with 40-100 % of intensity. This key 
fragment can be explained by the cleavage of the bond between the N atom and the two 
adjacent carbons with a loss of ammonia residue from both the two possible isobaric opened 
ions. These two latter species can easily loss the neutral groups, 1,4-diaminobutane and 1,3-
diaminopropane thus forming the ions at 348 m/z with higher intensity (50-100%) and the ion 
at 362 m/z, respectively. The ions at 291 m/z can originate by the loss of the 3-aminopropene 
group (57 Dalton) from the ion at 348 m/z. This fragmentation pattern is in agreement with that 
previously obtained by ESI-MS/MS experiments carried out on isolated cadabicine (Khanfar et 
al., 2003) and similar to that proposed for alkaloids extracted from root of Capparis decidua 
analyzed by FDMS (Arif,1986). 
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Figure 3. Some reference structures of the main alkaloids from C. spinosa root.  1, Cadabicine 
26-O-b-D-glucoside; 2, Capparispine; 3, Capparispine 26-O-b-D-glucoside; 4, 
Isocodonocarpine; 5, Capparisine; 6, Stachydrine. 
 
 
                                           
                                         1      2          R=H          3 R=Glucose                                                                                                                                              
4            5     6 
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Figure 4. MS/MS spectra of the ions at 436 m/z related to four isobars corresponding to 
capparispine or capparispine alkaloids in free forms.  
 
 
The structural hypothesis derived by the MS data agrees with the UV-Vis spectra of these 
molecules obtained by the HPLC/DAD analyses in water-acetonitrile and shown in Figure 
5.The isolated capparispine, capparisine and capparisinine alkaloids in methanol solution 
showed maximum absorptions in the range of 280-283 nm with shoulders close to 308-310 nm 
(Arif, 1986). More recently, other authors (Fu et al., 2008) have reported almost the same 
maximum absorptions for free capparispine and capparispine 26-O--D glucoside. The spectra 
in Figure 5 have been grouped and overlapped taking into account the similarities among all the 
detected compounds and compared with the spectra of the p-coumaric acid selected as 
reference to measure the alkaloid content in all the extracts (see next paragraph). 
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Figure 5. Some UV-Vis spectra of the detected alkaloids and other unknown derivatives in the root of 
C. spinosa. a) standard of p-coumaric acid;  b) 12,7 min, 13,2 min and 17,3 min; c) 11,7 min, 16,1 min 
and 16,3 min; d) 15,3 min 18,1 18,6 min and 19,1 min; e) 22,4 min, 22,8 min , 23,3 min,  23,9 min. 
 
a                                             b                                        c 
              
      d                                                               e 
  
 
All these spectra are in agreement with the presence of cynnamoyl moieties within the 
molecular structures that are characteristic of the main alkaloids of Capparidaceae (Figure 3). 
The presence of another important alkaloid, stachydrine, has been confirmed by the MS and 
MS/MS experiments, but for this structure the UV spectra is not useful nor informative. This 
more polar compound typical of Capparidaceae, with the protonated molecular ion at m/z 144 
[M+H]
+
, present an rt value of 1,5 min (Figure 1) almost coincident with the dead volume of 
the column. Our finding pointed out the interaction of this molecule with a C18 reverse phase 
(also starting the elution method with 98% of water) as negligible. In the same profile, 
according to the mass spectral data, it was possible to identify two monoglycosides at m/z 598 
[M+H]
+
 corresponding to compounds 1 and 2, that can be related to capparispine 26-O- -D-
glucoside and/or cadabicine 26-O- -D-glucoside, previously isolated from this root (Fu et al., 
2008). The group of peaks in the range of 15-18 min corresponds to four isobars at m/z 436 
[M+H]
+
 of capparispine and/or capparisine (compounds 3, 4, 5, 6 and 7 in Figure 1). Another 
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cluster of minor peaks between 18-21 min showed the presence of two main ions species at m/z 
466 [M+H]
+
 and m/z at 435 detected for the compounds 8, 9, 10. The molecular weight of 466 
Dalton suggests the presence of isocodonocarpine and/or codonocarpine, two isobaric alkaloids 
previously detected in Capparis decidua characterized by the presence of methoxyl groups on 
their structures that can explain the ion at m/z 435, due to a loss of 31 mu by the molecular ion 
species. 
Further MS and MS/MS experiments on hydroalcoholic and water extracts have been carried 
out in flow injection, aiming to verify the ability to detect the main alkaloids in the extract 
without the need of a chromatographic separation. The obtained findings confirm this 
hypothesis, in fact the ion at 436 m/z corresponding to the protonated ion of capparisine and 
capparispine, was easily detected with a good intensity. Furthermore, the presence of the 
corresponding monoglucoside species, even if in consistently lower amount, have been 
detected. Due to the very similar structures and behavior in fragmentation, it was not possible 
to distinguish the contribution of each single isobaric molecule both in MS and MS/MS 
experiments 
To the best of our knowledge, this is the first HPLC-DAD-MS profile that pointed out the 
copresence of stackydrine, several isobaric forms of capparispine and/or capparisine in free and 
glycosylated forms and some isobars of isocodonocarpine or codonocarpine all extracted from 
a sample of C. spinosa root. Overall, the proposed HPLC/DAD/MS method result as a suitable 
tool to investigate on the alkaloid content of this root while the flow injection of these different 
extracts resulted able only to give a qualitative picture of the main alkaloids of this root.  
 
Extractive yields in terms of alkaloid content 
The alkaloid content in the root was measured by HPLC/DAD through the use of p-coumaric 
acid as external standard. This phenol was selected because a similar structure is always 
present in the main alkaloids of C. spinosa (Figure 3) and represent the determinant moiety to 
define the shape of the UV-Vis spectrum of these alkaloids (Figure 5). Naturally, selecting this 
standard the molar absorbitivity of all the alkaloids measured at 280 nm, was assumed as the 
same of that of p-coumaric acid. This approach is frequently applied in the analyses of complex 
vegetal matrices when more specific and suitable standards are not available. 
The alkaloid content was determined in the extracts of whole root, but also on external and 
internal parts separately; Table 2 shows the recovery of some single alkaloids (compounds 1, 2, 
3 and 7) and the total amount obtained with the different extracts. The choice to use a 70% 
hydro alcoholic mixture was done for recovering the larger amount of the different alkaloids 
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only in one extractive step. At the same time also the decoction of root was applied because a 
similar procedure is described to prepare root extracts used in the traditional Arab and Greek 
popular medicine (Sher and Alyemeni, 2010; Moghaddasi et al.,2012).  
 
Sample Extract 
Part of 
root 
single alkaloid Total Alkaloids 
1 2 3 7 mg/g DR RSD 
S1 Dec whole 0,09±0,01 0,30±0,06 0,09±0,01 0,66±0,01 1,36±0,06 4,4 
S2 EtH2O whole 0,14±0,01 0,79± 0,01 0,18±0,006 1,23±0,02 2,75±0,02 0,7 
S3 
EtH2Os Root 
cortex 
0,20±0,05 1,25±0,22 0,19±0,03 1,39±0,10 3,81±0,03 0,8  
S4 EtH2Os Inner part 0,33±0,02 1,71±0,20 0,18±0,01 1,36±0,02 3,70±0,21 5,4 
S5 EtH2Os whole 0,31±0,03 1,52±0,12 0,18±0,01 1,38±0,02 3,92±0,03 0,8 
 
Table 2. Amount of the alkaloids in different extracts; the data are a mean of triplicates. 
 DE = Dried Extract; DR = Dried Root; Dec=decoction ;EtH2O= hydro alcoholic extract; 
EtH2Os hydro alcoholic extract with sonication  
 
The main findings regarding the extractive yields obtained with the different procedures 
summarized in of Table 2 can suggest some general considerations. As expected the total 
alkaloids expressed as mg/g DR is almost doubled (2,75±0,02) in EtH2O sample with respect to 
Dec sample. (1,36±0,07). Coupling the use of ultrasounds even if of low potency, with the 
ethanol mixture, an increment close to 30% of the extractive yield was  reached (3,9 mg/g dried 
root). Applying the same process to external and internal parts of the root similar values in 
terms of total content were observed. This result suggests that the distribution of the alkaloids 
studied in this work is homogeneous within the root of C. spinosa. Furthermore it can be 
assessed the ultrasounds strongly help to raises the extractive yield, the results are in agreement 
with previous data (Ensminger and Leonard 2011), the extractive procedure shown a good 
reproducibility as confirmed by the RSD values in Table 2. 
 
Composition of the extracts 
The next step of this investigation was focused to apply a procedure to obtain extracts more 
concentrated in terms of alkaloids, suitable for MS investigations aimed to check the presence 
of minor alkaloids but mainly to evaluate the bioactivities of the alkaloids of root. To this latter 
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scope and according to the traditional uses, several extracts with different alkaloid composition 
have been selected for in vivo tests to evaluate their ability in reducing neuropathic pain in rats 
after oral administration (see chapter 7 of this thesis). 
In literature a common procedure to recover different pools of alkaloids from complex vegetal 
matrices is to work at alkaline pH. In this medium, avoiding the positive charges on the 
nitrogen atoms, a liquid/liquid extraction by lipophilic solvents as dichloromethane and 
chloroform usually guarantees an efficient recovery of these molecules from aqueous residues. 
To this aim, the process summarized in Figure 6 applies this concept to fractionate the hydro 
alcoholic extract of the root for obtaining a partially purified fraction enriched in the non 
glycosilated alkaloids of capparisine and/or capparispine.  
 
Figure 6. Scheme of the fractionation process applied to concentrate the alkaloid fraction 
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The alkaloid content of all the samples obtained by a direct extraction of the root or by the 
fractionation process of Figure 6 has been expressed with respect to the weight of the dried 
extract and compared in Table 3 and Figure 7.  
 
Table 3. Alkaloid content in the extracts derived by the fractionation process of Figure 6 
compared with the decoction and hydro alcoholic extract of whole root. 
 
Sample Extracts 
Part 
root 
main alkaloids 
(mg/g) 
Total Alkaloids 
(mg/g DE) 
1 2 3 7  
S1 DEC Whole 0,36 1,27 0,4 2,79 5,72 
S2 EtH2O Whole 0,54 3,15 0,73 4,92 11,0 
S6 CH2Cl2 Whole 0 1,67 7,37 57,39 76,53 
S7 H2O-Res Whole 0,48 2,93 0,25 1,28 5,70 
 
 
Figure 7. Distribution of the main alkaloids within root cortex (external) and inner 
root(internal) ; data as a mean of triplicates expressed on weight of dried extract (DE). 
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By the HPLC/DAD/MS analyses it was confirmed an increased amount of the glycosilated 
forms (alkaloids 1 and 2) in the aqueous residue (H2O-Res) and an higher amount of free 
alkaloids in the organic phase (CH2Cl2). Overall this latter sample contain the largest amount of 
alkaloids up to 76,53 mg/g DE. The use of ethyl acetate (EtOAc) after methylene chloride does 
not give a more selective fractionation nor increased amounts of alkaloids (data not shown) . 
Overall, the use of methylene chloride (Figure 6) allowed to increase the alkaloids amount 
almost of 7 times with respect to the native hydro alcoholic sample as evidenced comparing the 
data in table 3 with the; in light of this data the extract resulted eligible for biological tests 
focused on evaluating the activity of these pool of alkaloids (see chapter 7 of this thesis).   
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Abstract 
 
Ethnopharmacological relevance. Capparis spinosa L. originates from dry regions of Asia 
and Mediterranean basin. In traditional medicine of these areas, infusions from caper root are 
considered to be beneficial for the treatment of rheumatism, gout and against abdominal 
pains. 
Aim of the study. To evaluate the pain reliever properties of a Syrian cultivar of Capparis 
spinosa roots in rat models of osteoarthritis and rheumatoid arthritis.  
Materials and Methods. Decoction (DEC) and hydroalcoholic extract (EtH2O) were obtained 
from powdered roots; the latter was further separated in CH2Cl2 and aqueous (H2O-Res) 
fractions. The extracts were characterized in terms of spermidine alkaloids by 
HPLC/DAD/MS and stachydrine by NMR. Different amount of free and glycosilated forms of 
capparispine and analogues (from 0.5 % w/w for DEC up to 7.6 % w/w for CH2Cl2 fraction) 
were detected. Rat models of rheumatoid arthritis and osteoarthritis were induced by the intra-
articular administration of Complete Freund’s Adjuvant (CFA) or monosodium iodoacetate 
(MIA), respectively.  
Results. Fourteenth days after CFA or MIA injection, the different preparations of Capparis 
spinosa (3, 30, 100 and 300 mg kg
-1
) were acutely administered per os. Powdered roots (300 
mg kg
-1
), DEC (100 mg kg
-1
), and EtH2O (300 mg kg
-1
) significantly reduced hypersensitivity 
to mechanical noxious stimuli as well as spontaneous pain evaluated as hind limb bearing 
alterations in both models. The CH2Cl2 and the H2O-Res (30 mg kg
-1
) were the most potent in 
reverting pain threshold alterations despite the different content of free alkaloids.  
 
 
 
 
124 
 
 
 
 
 
 
Introduction 
The traditional use of Capparis spinosa root as remedy against different pains in human is 
well known since the antiquity as highlighted by a recent review (Jiang et al, 2007). The 
powdered root is widely use for oral administration in the Syrian tradition, alone or associated 
to local applications on the painful part of “dough” prepared mixing the powder with water. In 
Jordanian traditional medicine, the root bark are macerated and placed between gauze on 
aching area for 15-25 min in order to relieve the inflammation and muscle pain (Hudaib et al., 
2008). This ability to reduce pain in humans is particularly interesting because few natural 
compounds have been recognized as efficacious to date. 
According to the traditional uses of this root overall in the medium-oriental area, aim of this 
study was to evaluate by in vivo models the ability of some extracts obtained by a Syrian 
sample of Capparis spinosa L. root to reduce the osteoarticular pain. The study was carried 
out with four different Capparis spinosa extracts tested in inflammatory and osteoarticular rat 
pain models. Pain was measured by paw pressure and hind limb weight bearing alterations 
tests measuring the effects over time from 15 to 60 min after the oral administration. 
 
Material and Methods 
Complete Freund’s Adjuvant-Induced Inflammatory Arthritis 
Articular damage was induced by injection of complete Freund’s adjuvant (CFA, Sigma-
Aldrich) into the right knee joint. Briefly, the rats were slightly anesthetized by 2% isoflurane, 
the left leg skin was sterilized with 75% ethyl alcohol, and the lateral malleolus located by 
palpation; then, a 28-gauge needle was inserted vertically to penetrate the skin and turned 
distally for insertion into the articular cavity at the gap between the tibiofibular and tarsal 
bone until a distinct loss of resistance was felt. A volume of 50 μL of CFA was then injected 
(day 0). The paw pressure and the incapacitance tests (see below) were performed 14 days 
after CFA injection.  
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Monoiodoacetate-Induced Osteoarthritis 
Knee osteoarthritis was induced by injection of monoiodoacetate (MIA, Sigma-Aldrich) into 
the right knee joint. On day 0, rats were slightly anesthetized by 2% isoflurane, the left leg 
skin was sterilized with 75% ethyl alcohol, and the lateral malleolus located by palpation; 
then, a 28-gauge needle was inserted vertically to penetrate the skin and turned distally for 
insertion into the articular cavity at the gap between the tibiofibular and tarsal bone until a 
distinct loss of resistance was felt. 2 mg MIA in 25 μL saline was delivered into the left 
articular cavity. The paw pressure and the incapacitance tests (see below) were performed at 
day 14.  
 
Drug treatments 
All the extracts reported in Table 1 were suspended in 1% CMC and administered per os. The 
different doses were measured as dried amount of the corresponding extracts.  
The preparation of the root samples has been reported in the chapter 6 of this Thesis; the 
following samples were evaluate: the hydroalcoholic extract (EtH2Os), the decoction (DEC), 
the methylenchloride extract (CH2Cl2) and its correlated aqueous residue(H2O-Res). All the 
dried extracts were suspended in 1% CMC and administered per os. 
 
Paw pressure test 
The nociceptive threshold in rats was determined with an analgesimeter (UgoBasile, Varese, 
Italy), according to the method described by Leighton et al.(1988). Briefly, a constantly 
increasing pressure was applied to a small area of the dorsal surface of the paw using a blunt 
conical probe by a mechanical device. Mechanical pressure was increased until vocalization 
or a withdrawal reflex occurred while rats were lightly restrained. Vocalization or withdrawal 
reflex thresholds were expressed in grams. Rats scoring below 40 g or over 75 g during the 
test before drug administration (25%) were rejected. An arbitrary cut-off value of 250 g was 
adopted. Fourteen days after the operation rats were tested twice in 30 min and mean was 
shown. The data were collected by an observer who was blinded to the protocol. 
 
Incapacitance test 
Weight bearing changes were measured using an incapacitance apparatus (Linton 
Instrumentation, UK) detecting changes in postural equilibrium after a hind limb injury. Rats 
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were trained to stand on their hind paws in a box with an inclined plane (65° from horizontal). 
This box was placed above the incapacitance apparatus. This allowed us to independently 
measure the weight that the animal applied on each hind limb. The value considered for each 
animal was the mean of 5 consecutive measurements. In the absence of hind limb injury, rats 
applied an equal weight on both hind limbs, indicating a postural equilibrium, whereas an 
unequal distribution of the weight on hind limbs indicated a monolateral decreased pain 
threshold. Data are expressed as the difference between the weight applied on the limb 
contralateral to the injury and the weight applied on the ipsilateral one (Δ Weight). 
 
Preliminary results 
Effects of Capparis spinosa on CFA-Induced Inflammatory Arthritis 
With the aim of testing the pharmacological activity of Capparis spinosa root in articular 
inflammatory damage resembling human rheumatoid arthritis, the extracts were evaluated in 
the CFA-model. The pain threshold was measured 14 days after intra-articular CFA injection 
by paw pressure and incapacitance tests. The mechanical withdrawal threshold in ipsilateral- 
(CFA + saline) treated paw was significantly reduced as compared to the controlateral paw 
and control animals (saline + saline). The dried hydroalcoholic extract (at the doses of 300, 
100 and 30 mg kg−1), 15 minutes after administration, increased the withdrawal threshold and 
was still effective after 45 minutes. At the dose of 3 mg kg−1 was effective only 15 minutes 
after administration(Table 1).  
CH2Cl2 extract 10 mg kg
−1
was also active for the first 45 minutes (Table 2),while the aqueous 
extract (100 and 30 mg kg
-1
) increased the withdrawal threshold and was still effective after 
60 minutes (P<0.05, Table 3). Decoction was effective at 100 and 30 mg kg−1forthe first 60 
min (Table 4).  
Incapacitance test confirmed these results. Capparis spinosa L. extracts significantly reduced 
hind paw unbalance in a time-dependent manner, being particularly effective 45 min after 
administration (data not shown). Decoction, at the dose of 30 mg kg
-1
, showed activity until 
75 minutes (P<0.05) as reported in Table 5. 
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Table 1. Effect of single administration of Capparis spinosa hydro alcoholic extract   on CFA induced 
rheumatoid arthritis in the rat: Paw pressure test 
 Weight (g) 
Treatment Paw
 
Pretest 15 min 30 min 45 min 60 min 
Sham + 
vehicle 
ipsilateral 65.8  0.8 64.1  0.0.8 64.2  0.1 64.1  0.8 65.0  1.4 
contralateral 64.1  0.8 63.3  0.8 64.1  0.8 64.1  0.8 64.2  0.8 
CFA + C. 
spinosa 300 
mg kg
-1
 
ipsilateral 44.0  0.6** 66.0  1.1^^ 62.0  1.0^^ 52.5  1.3^^ 46.5  0.6 
contralateral 65.5  1.0 66  1.1 65.5  0.5 64.5  1.0 65.0  1.2 
CFA + C. 
spinosa 100 
mg kg
-1
 
ipsilateral 42.5  1.3** 56.5  0.7^^ 54.5  1.0^^ 49.0  0.1^^ 45.0  0.8 
contralateral 66.0  1.9 65.0  0.8 64.5  1.0 64.5  1.0 62.5  0.8 
CFA + C. 
spinosa 30 mg 
kg
-1
 
ipsilateral 44.5  0.5** 55.5  1.0^^ 53.5  0.6^^ 49.0  0.6^^ 47.0  0.6^^ 
contralateral 63.0  1.0 65.0  1.5 64.0  0.6 65.5  0.6 62.5  0.8 
CFA + C. 
spinosa 3 mg 
kg
-1
 
ipsilateral 46.0  1.1** 52.0  1.6^^ 49.0  1.1 48.0  1.4 46.0  1.4 
contralateral 64.5  1.3 65.5  1.0 64.0  1.1 63.5  1.7 64.0  0.7 
*P<0.05 and **P<0.01 vs sham + vehicle treated animals; ^P<0.05 and ^^P<0.01 vs CFA + Capparisspinosa dose 
mg kg
-1
 (pretest) treated animals. Each value represents the mean of 5 rats. 
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Table 2. Effect of single administration of Capparis spinosa CH2Cl2 extract on CFA induced rheumatoid arthritis 
in the rat: Paw pressure test 
 Weight (g) 
Treatment Paw
 
Pretest 15 min 30 min 45 min 60 min 
Sham + vehicle 
ipsilateral 65.8  0.8 65.0  1.4 65.8  0.8 
64.2  
0.8 
64.2  0.8 
contralateral 63.3  0.8 65.0  1.4 65.0  0.8 
64.2  
2.0 
63.3  0.8 
CFA + C. spinosa 
30 mg kg
-1
 
ipsilateral 41.2  0.7** 64.2  0.7^^ 56.7  1.4^^ 
50.0  
1.3 
44.2  0.7 
contralateral 65.8  0.7 65.8  0.7 65.0  1.3 
64.2  
0.7 
64.2  0.7 
CFA + C. spinosa 
10 mg kg
-1
 
ipsilateral 43.3  0.7** 60.8  0.7^^ 55.8  0.7^^ 
55.0  
0.5^^ 
43.3  0.7 
contralateral 64.2  0.7 64.2  0.7 65.0  1.3 
62.5  
1.3 
62.5  1.3 
CFA + C. spinosa 
3 mg kg
-1
 
ipsilateral 44.2  0.7** 50.8  0.7^^ 49.2  0.7^ 
45.8  
0.7 
44.2  0.7 
contralateral 65.0  1.3 63.3  1.9 65.0  1.3 
62.5  
1.3 
64.2  1.9 
*P<0.05 and **P<0.01 vs sham + vehicle treated animals; ^P<0.05 and ^^P<0.01 vs CFA + Capparis spinosa dose mg 
kg
-1
 (pretest) treated animals. Each value represents the mean of 5 rats. 
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Table 3. Effect of single administration of Capparis spinosa aqueous extract on CFA induced rheumatoid arthritis in 
the rat: Paw pressure test 
 Weight (g) 
Treatment Paw
 
Pretest 15 min 30 min 45 min 60 min 75 min 
Sham + 
vehicle 
ipsilateral 65.8  0.8 65.0  1.4 65.8  0.8 64.2  0.8 64.2  0.8 64.2  0.8 
contralateral 63.3  0.8 65.0  1.4 65.0  0.8 64.2  2.0 63.3  0.8 64.2  0.8 
CFA + C. 
spinosa 
100 mg kg
-
1
 
ipsilateral 43.3  1.4** 65.0  1.2^^ 64.1  0.7^^ 56.7  0.7^^ 51.7  0.7^ 46.7  0.7 
contralateral 65.8  0.7 66.7 0.7 64.1  0.7 65.8  0.7 65.0  1.3 65.0  1.3 
CFA + C. 
spinosa 30 
mg kg
-1
 
ipsilateral 45.0  1.3** 65.8  0.7^^ 60.0  0.5^^ 54.2  0.7^^ 47.5  2.1^ 44.2  0.7 
contralateral 65.0  1.3 63.3  1.4 62.5  1.3 62.5  1.3 63.3  0.7 64.2  0.7 
CFA + C. 
spinosa 3 
mg kg
-1
 
ipsilateral 45.8  0.7** 57.5  0.3^^ 58.3  0.7^^ 48.3  0.7 45.8  0.7 n.d. 
contralateral 60.8  0.4 63.3  0.7 64.2  0.7 63.3  0.7 64.2  0.7 n.d. 
*P<0.05 and **P<0.01 vs sham + vehicle treated animals; ^P<0.05 and ^^P<0.01 vs CFA + Capparisspinosa dose mg kg
-1
 
(pretest) treated animals. Each value represents the mean of 5 rats. 
 
Table 4. Effect of single administration of Capparisspinosa decoction on CFA induced rheumatoid arthritis in the 
rat: Paw pressure test 
 Weight (g) 
Treatment Paw
 
Pretest 15 min 30 min 45 min 60 min 75 min 
Sham + vehicle 
ipsilateral 65.8  0.8 65.0  1.4 65.8  0.8 64.2  0.8 64.2  0.8 64.2  0.8 
contralateral 63.3  0.8 65.0  1.4 65.0  0.8 64.2  2.0 63.3  0.8 64.2  0.8 
CFA + C. 
spinosa 100 mg 
kg
-1
 
ipsilateral 
42.9  
0.9** 
68.3  
0.9^^ 
64.2  
0.9^^ 
52.9  
0.3^^ 
48.7  1.0^ 43.4  0.6 
contralateral 64.2  0.7 69.2  1.4 66.7  0.3 64.6  0.9 64.6  0.9 65.2  0.5 
CFA + C. 
spinosa 30 mg 
kg
-1
 
ipsilateral 
44.2  
0.7** 
61.7  
0.7^^ 
58.3  
0.7^^ 
53.3  
0.7^^ 
49.2  0.7^ 45.8  0.7 
contralateral 65.0  1.3 65.0  1.3 64.2  0.7 64.2  0.7 63.3  0.7 63.3  0.7 
CFA + C. 
spinosa 3 mg 
kg
-1
 
ipsilateral 
45.8  
1.4** 
55.0  
0.5^^ 
52.5  1.3^ 46.7  0.7 45.0  0.5 n.d. 
contralateral 65.0  0.5 65.8  0.7 65.0  0.5 65.0  0.5 64.2  0.7 n.d. 
*P<0.05 and **P<0.01 vs sham + vehicle treated animals; ^P<0.05 and ^^P<0.01 vs CFA + Capparisspinosa dose mg kg
-1
 
(pretest) treated animals. Each value represents the mean of 5 rats. 
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Table 5. Effect of single administration of Capparisspinosa decoction on CFA induced rheumatoid arthritis in the rat:  
Incapacitance test 
 Weight (g) 
Treatment 
Pretest 15 min 30 min 45 min 60 min 75 min 90 min 
Difference 
score 
(contralateral 
– ipsilateral 
paw) 
Difference 
score 
(contralater
al – 
ipsilateral 
paw) 
Difference 
score 
(contralatera
l – 
ipsilateral 
paw) 
Difference 
score 
(contralateral 
– ipsilateral 
paw) 
Difference 
score 
(contralatera
l – 
ipsilateral 
paw) 
Difference 
score 
(contralater
al – 
ipsilateral 
paw) 
Differenc
e score 
(contralat
eral – 
ipsilateral 
paw) 
Sham + vehicle 1.9  2.7 -2.2  3.2 2.0  1.0 3.3  3.7 2.1  1.8 3.7  0.5 2.0  0.7 
CFA + C. spinosa 
100 mg kg
-1
 
62.4  1.4** 
13.5  
1.5^^ 
15.3  2.8^^ 25.2  2.4^^ 38.6  0.9^^ 57.9  1.3  n.d. 
CFA + C. spinosa 
30 mg kg
-1
 
61.3  0.2** 
12.9  
0.9^^ 
21.2  1.0^^ 31.1  1.3^^ 46.2  2.4^^ 56.5  2.3^ 60.1  0.5 
CFA + C. spinosa 
3 mg kg
-1
 
49.6  0.9** 
39.0  
0.8^^ 
47.1  1.5 49.3  4.2 56.0  1.1 n.d. n.d. 
*P<0.05 and **P<0.01 vs sham + vehicle treated animals; ^P<0.05 and ^^P<0.01 vs CFA + Capparisspinosa dose mg kg
-1
 
(pretest) treated animals. Each value represents the mean of 5 rats. 
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Effect of Capparisspinosa on MIA-Induced Osteoarthritis 
The effectiveness of capparis extracts was evaluated in the rat osteoarthritis induced by MIA. 
Fourteen days after MIA, the weight tolerated on the ipsilateral paw (MIA + saline) was 
significantly reduced as compared to the contralateral paw and control animals (saline + 
saline). 
Hydroalcoholic extract (300 mg kg
−1
), 15 minutes after p.o. administration,increased the 
withdrawal threshold and was still effective after 45 minutes. At the dose of 100 and 30 mg 
kg
-1
 it was effective until 45 minutes(Table 6). 
 
Table 6. Effect of single administration of Capparisspinosahydroalcoholic extract on MIA induced knee 
osteoarthritis in the rat: Paw pressure test 
 Weight (g) 
Treatment Paw
 
Pretest 15 min 30 min 45 min 60 min 
Sham + 
vehicle 
ipsilateral 62.5  1.4 64.2  0.8 64.2  0.8 64.2  0.8 64.2  0.8 
contralateral 64.2  0.8 62.5  1.4 63.3  0.8 65.0  1.4 64.2  0.8 
MIA + C. 
spinosa 300 
mg kg
-1
 
ipsilateral 40.6  0.6** 59.3  0.6^^ 53.1  0.6^^ 48.1  0.6^^ 40.6  0.1 
contralateral 64.2  0.8 64.4  0.6 64.4  1.2 64.3  0.6 63.7  1.6 
MIA + C. 
spinosa 100 
mg kg
-1
 
ipsilateral 40.6  0.6** 53.7  1.3^^ 49.4  0.6^^ 45.0  1.0^ 43.1  1.2 
contralateral 66.8  0.6 65.0  1.8 65.6  1.2 63.8  0.7 64.4  1.6 
MIA + C. 
spinosa 30 mg 
kg
-1
 
ipsilateral 43.1  1.2** 54.4  0.6^^ 50.6  0.6^^ 48.1  0.6^ 44.4  0.6 
contralateral 64.3  1.6 63.8  1.6 63.4  0.7 63.8  1.6 63.8  0.7 
*P<0.05 and **P<0.01 vs sham + vehicle treated animals; ^P<0.05 and ^^P<0.01 vs MIA + Capparisspinosa 
dose mg kg
-1
 (pretest) treated animals. Each value represents the mean of 5 rats. 
 
CH2Cl2 extract showed the same effectivenessthan hydroalcoholic extractat the doses of 30 
and 10mg kg
−1
. Moreover, the aqueous extract significantly reduced hind limb weight bearing 
alterations, being effective until 60 minutes after administration at the dose of 100 mg kg
-1
 
(data not shown). Regarding the decoction, at the doses of 100 and 30 mg kg
-1
 it was effective 
until 45 minutes (P<0.05); the dose of 3 mg kg
-1
showed also effectiveness until 30 min (data 
not shown). 
Incapacitance test confirmed the effect ofCapparisspinosa extracts to reduce hind paw 
unbalance in rat; in particular the aqueous extract at the dose of 100 mg kg
-1
 showed 
132 
 
effectiveness until 75 minutes (Table 7). Decoction showed activity only for the first 45 
minutes (P<0.05). 
 
 
 
Table 7. Effect of single administration of Capparisspinosa aqueous extract on MIA induced knee osteoarthritis 
in the rat: Incapacitance test 
 Weight (g) 
Treatment 
Pretest 15 min 30 min 45 min 60 min 75 min 90 min 
Difference 
score 
(contralatera
l – ipsilateral 
paw) 
Differenc
e score 
(contralat
eral – 
ipsilateral 
paw) 
Difference 
score 
(contralater
al – 
ipsilateral 
paw) 
Difference 
score 
(contralater
al – 
ipsilateral 
paw) 
Difference 
score 
(contralater
al – 
ipsilateral 
paw) 
Difference 
score 
(contralater
al – 
ipsilateral 
paw) 
Difference 
score 
(contralate
ral – 
ipsilateral 
paw) 
Sham + vehicle 1.9  2.7 -2.2  3.2 2.0  1.0 3.3  3.7 2.1  1.8 3.7  0.5 2.0  0.7 
CFA + C. spinosa 
100 mg kg
-1
 
63.0  2.1** 
3.6  
1.3^^ 
18.0  
4.3^^ 
24.2  
0.8^^ 
33.5  
2.0^^ 
51.8  
0.2^^ 
60.1  2.5 
CFA + C. spinosa 
30 mg kg
-1
 
66.6  5.2** 
13.5  
1.4^^ 
23.0  
0.6^^ 
33.5  
1.0^^ 
52.9  2.7 n.d. n.d. 
CFA + C. spinosa 
3 mg kg
-1
 
53.6  1.6** 
30.9  
0.6^^ 
29.9  
0.5^^ 
41.3  
1.0^^ 
53.7  0.1 n.d. n.d. 
*P<0.05 and **P<0.01 vs sham + vehicle treated animals; ^P<0.05 and ^^P<0.01 vs MIA + Capparisspinosa dose mg 
kg
-1
 (pretest) treated animals. Each value represents the mean of 5 rats. 
 
 
 
These preliminary results show that the aqueous extracts provided the best results, and the 
polar metabolites appear to be the most effective. On the contrary, the alkaloids (capparisina 
and its analogues) not seem to be the most active molecules. 
However, other chemical characterization studies are needed. 
In table 8  is shown the alkaloid content of the 4 tested  samples expressed as total amount and 
as main alkaloids 
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Table 8: Alkaloid content in the extracts derived by a fractionation process carried out at alkaline pH 
compared with the decoction and hydro alcoholic extract of whole root. 
 
Sample Extracts 
Part of the 
root 
main alkaloids 
(mg/g) 
Total 
Alkaloids 
(mg/g DE) 
1 2 3 7  
S1 DEC Whole 0,36 1,27 0,4 2,79 5,72 
S2 EtH2O Whole 0,54 3,15 0,73 4,92 11,0 
S6 CH2Cl2 Whole 0 1,67 7,37 57,39 76,53 
S7 H2O-Res Whole 0,48 2,93 0,25 1,28 5,70 
 
 
In light of the results shown in Tables 1--7 the aqueous extracts, DEC and H2O-Res, have 
been  resulted as more efficacious if compared with  the EtH2O and CH2Cl2 samples. These 
preliminary data suggest that the main alkaloids of Capparis spinosa, more concentrated in 
the CH2Cl2 extract and EtH2O seem to be not the more active compounds in these in vivo 
test. Further studies are in progress to improve the knowledge on  the composition of these  
aqueous extracts and to identify the main active metabolites of this root.  
 
